Michael S. Gelfand, M.D., F.A.C.P. 1

January 2017CURRICULUM VITAE

Michael S. Gelfand, M.D., F.A.C.P.

Birth: Moscow, USSRU.S. Citizen, 1980

Telephone: (901) 448-5770 Fax: (901)-685-0044

E-mail: mgelfand@uthsc.edu

Medical School: First Moscow Medical SchoolMoscow, USSRJuly, 1970-June, 1974

University of Texas Southwestern Medical SchoolDallas, TexasSeptember, 1975 - June, 1977

Internship: Straight Medical InternshipBaylor University Medical CenterDallas, TexasJuly, 1977 - June, 1978

Residency: Internal Medicine ResidencyBaylor University Medical CenterDallas, TexasJuly, 1978 - June, 1980

Fellowship: Fellow in Infectious Diseases andClinical MicrobiologyVanderbilt University Medical CenterNashville, TennesseeJuly, 1980 - June, 1982

Certification: Diplomate, National Board of Medical Examiners, 1978

Diplomate, American Board of Internal Medicine, 1980; Voluntary Recertification - 2002

Diplomate, American Board of Infectious Diseases, 1982; Voluntary Recertification - 2002 Licensure: Texas – 1977 (Inactive)

Tennessee – 1980

Professional Societies:

Member, American College of Physicians, 1977Fellow, American College of Physicians/American Society of Internal Medicine, 1987Member, Infectious Diseases Society of America 1982Fellow, Infectious Diseases Society of America, 1990

Member, HIV Medicine Association

Michael S. Gelfand, M.D., F.A.C.P. 2

Member, American Society for Microbiology 1980 Member, The Transplantation Society Member, The Transplantation Society Infectious Diseases Section

Member, Memphis and Shelby County Medical SocietyMember, Memphis Academy of Internal MedicineMember, Tennessee Medical AssociationMember, Society of Hospital Epidemiologist of America, 1982

Fellow, Society for Healthcare Epidemiology of America Member, American Physicians Fellowship for Medicine in Israel

Current Positions: Professor of Medicine (tenured )

University of Tennessee Health Science Center – Memphis 7/1/03 - Present

Faculty, Infectious Diseases, UTMP 10/1/13 - Present

Chief, Division of Infectious DiseasesMethodist University Hospital of Memphis1982 - Present

Assistant Director of Infection ControlMethodist Hospitals of Memphis1984 – Present

Faculty, UT-Hebrew University Medical Student Exchange Program1997 - Present

Attending Physician - Infectious DiseasesUniversity of TennesseeCollege of Medicine1982 - Present

Faculty, University of Tennessee Medical StudentsIntroduction to Clinical Skills Course1982 - Present

Faculty, University of Tennessee Senior Medical StudentsElective in Infectious Diseases1983 – Present

Consultant, Adult Infectious Diseases, BMT program of

St Jude’s Children’s Research Hospital, Memphis, TN

Previous Positions: Private Practice of Infectious DiseasesJuly, 1982 – 6/30/03

Faculty, Infectious Diseases, UTMG 7/1/2003-9/30/2013

Clinical Professor of MedicineUniversity of Tennessee Medical College, Memphis7/1/96 – 6/30/03Associate Director of Internal Medicine1992 - 2000

Michael S. Gelfand, M.D., F.A.C.P. 3

President Tennessee Infectious Disease Society August, 1998 - August 2000

Medical Director of Organ Transplantation ProgramMethodist Hospitals of Memphis1987 - 1999

Treasurer, Tennessee Infectious Diseases Society1993 - 1996

Director of Internal MedicineMethodist Hospitals of Memphis1983 – 1987

Chair, P&T committee, Methodist Healthcare, 1988-2007

Hospital EpidemiologistMethodist Hospitals of Memphis1982 - 1984

Physical Diagnosis InstructorSouthwestern Medical School Students1978 - 1980

Associate Director, Clinical Microbiology LaboratoryMethodist Hospitals of Memphis1986 - 1989

Consultant in Infectious DiseaseDuckworth Pathology Group1985 - 1989

Associate Director of Internal MedicineMethodist Hospitals of Memphis1987 - June 1991

Director of Internal MedicineMethodist Hospitals of MemphisJuly 1991 - September 1992

Chairman, AID to Russia CommitteeSHEA1993 - 1994

Clinical Assistant Professor of MedicineUniversity of Tennessee Medical College, Memphis7/1/82 - 7/1/84

Clinical Associate Professor of MedicineUniversity of Tennessee College of Medicine, Memphis7/1/84 - 7/1/96

Pharmacy and Therapeutics Committee Chairman 1987-2007

Michael S. Gelfand, M.D., F.A.C.P. 4

Secretary-Treasurer, TN ID Society, Feb 2008-2009

Member, Fever and Neutropenia Panel, National Comprehensive Care Network

Attending Physician, University of Tennessee Blood and Bone Marrow Transplantation Service – 7/2001 – 12/2011

Previous memberships: Member, American Medical Association, 1988-2009

Member, Infectious Diseases Society of Tennessee 1987-2009

Honors: Listed in "The Best Doctors in America" 1996-present

Listed in the best doctors in Memphis "Memphis"Magazine 1996, 1999, 2002 and 2004

Health Care Heroes Award of the Memphis Business Journal4/29/99

Miracles in Motion AwardMethodist Healthcare 12/21/2000

“America’s Top Physicians” – Consumer’s Research Council of America - 2008

2004 Best CME Program Greenwood Leflore Hospital, Greenwood, MS

Study Groups: Member, Emerging Infections Network (EIN) - from 1997

Committees: Infection PreventionContinuing Medical Education

Antibiotic Stewardship

Public Relations:

Interview with The Commercial AppealMemphis, TennesseeSeptember 18, 1985 issue"Spider May Give Wallop of Pull Punch"

"Call the Doctor"WHBQ Radio Talk Show on Animal Related InfectionsMemphis, TennesseeJuly 15, 1986

Lecture on "AIDS"Heritage Presbyterian ChurchMemphis, TennesseeJanuary 8, 1987

Interview with The Commercial AppealMemphis, TennesseeMay 23, 1991

Michael S. Gelfand, M.D., F.A.C.P. 5

"TB is Making a Grim Comeback"

Lecture on "AIDS: The Obligation to Treat..."Beth Shalom Social HallMemphis, TennesseeMay 18, 1993

Interview with Channel 3 TV on West Nile Encephalitis 6/24/03

Interview with Memphis Medical News February 2014 – “Physicians’ Steps for Legal Recourse Shaky” by Emily Adams Keplinger

Interview with FOX 13 TV channel: Powerful drug that can have damaging effect ( fluoroquinolone antibiotics) – 11/4/2015

Publications:

1. "Medical Management of Visceral Actinomycosis." Walter Schlech, III, M.D., Michael Gelfand, M.D., Benjamin Alper, M.D., and Allen B. Kaiser, M.D. So. Med. J., 7/83;76:921-2.

2. "Streptococcus Bovis Endocarditis and Squamous-Cell Carcinoma of the Mouth.” Michael S. Gelfand, M.D., R.H. Alford, M.D., F.A.C.P. St. Thomas Hospital. NEJM 7/30/81;305:284-5.

3. "Tularemia and Rhabdomyolysis." Allen B. Kaiser, M.D., Dwaine Rieves, M.D., Ann H. Price, M.D., Michael S. Gelfand, M.D., Richard E. Parrish, M.D., Michael D. Decker, M.D., and Martin E. Evans, M.D. JAMA, 1985;253:241-244.

4. "Nosocomial Herpes Simplex Infections." Bryan P. Simmons, M.D. and Michael S. Gelfand, M.D. Infection Control, 1986;7:380-383.

5. "Toxic Shock in a Hospital Employee Due to Methicillin-Resistant Staphylococcus aureus." Bryan P. Simmons, M.D., Charles W. Munn, and Michael Gelfand, M.D. Infection Control, 1986;7:7.

6. "Rocky Mountain Spotted Fever and Sensory Neuropathy." Thomas S. Ahern, M.D., Michael S. Gelfand, M.D., and Bryan P. Simmons, M.D. Journal of the Tennessee Medical Association, Dec. 1986;79(12).

7. "Pneumococcal Vertebral Osteomyelitis in an Adult." Michael S. Gelfand, M.D. Southern Medical Journal, April 1987, Vol. 80, No. 4.

8. “Sucralfate for Stress Ulcer Syndrome” letter to the editor. Bryan Simmons, Michael Gelfand. Journal of Intensive Care Medicine 1988;3:233

9. "Brain Abscess: Association with and Hereditary Hemorrhagic Telangiectasia: Report of Three Cases." Michael S. Gelfand, M.D., David S. Stephens, M.D., Everett I. Howell, M.D., Robert H. Alford, M.D., and Allen B. Kaiser, M.D. The American Journal of Medicine, November 1988, Vol. 85:718-720.

10. "Ticarcillin-Clavulanic Acid (Timentin) Therapy of Infections with Ticarcillin-Resistant Microorganisms." Michael S. Gelfand, M.D., Ronald D. Lawson, M.D., and William Baucom, M.D. Southern Medical Journal, April 1989, Vol. 82, No. 4:433-437.

11. "Magnetic Resonance Imaging of the Brain in Bacterial Endocarditis." Tulio E. Bertorini, M.D., Robert E. Laster, Jr., M.D., Barry F. Thompson, M.D., and Michael Gelfand, M.D. Archives of Internal Medicine, April 1989, Vol. 149:815-817.

12. "CDC Group HB-5 as a Cause of Genitourinary Infections in Adults." Larry M. Baddour, M.D., Michael S. Gelfand, M.D., Robert E. Weaver, M.D., Toni C. Woods, M.D., Martin Altwegg, M.D., Leonard W. Mayer, M.D., Rose A. Kelley, M.D., and Don J. Brenner, M.D. Journal of Clinical Microbiology, May 1989; Vol. 27, No. 5:801-805.

13. "Staphylococcal Pyomyositis With Idiopathic Dermatomyositis." Michael S. Gelfand, M.D., Rodney Holladay, M.D., Tulio Bertorini, M.D., and R.Franklin Adams, M.D. Journal of the Tennessee Medical Association May 1989:243-244.

14. "Candida Tropicalis." Michael S. Gelfand, M.D. Infection Control Hospital Epidemiology, 1989;10:280-283.15. "Tularemia and Atypical Lymphocytosis." Michael S. Gelfand, M.D., Neera Mehra, M.D., and Bryan P. Simmons,

M.D. Journal of the Tennessee Medical Association, August 1989:417-418.16. "Enterobacter Sakazakii Infections in Neonates Associated with Intrinsic Contamination of a Powdered Infant

Formula." Bryan P. Simmons, M.D., Michael S. Gelfand, M.D., Michael Haas, M.T., Linda Metts, RN, and John Ferguson, M.D. Infection Control Hospital Epidemiology, 1989:10(9):398-401.

Michael S. Gelfand, M.D., F.A.C.P. 6

17. "CDC Group HB-5: A Newly Recognized Genitourinary Pathogen in Adults." Michael S. Gelfand, M.D. Infectious Diseases Newsletter, 8(6), June 1989:44.

18. "Nocardia and AIDS: A Case Report." Michael S. Gelfand, M.D., Bryan P. Simmons, M.D., and Charles J. DePaolo, M.D. Infectious Disease Newsletter, 8(8), August 1989.

19. "Localized Brucellosis: Popliteal Artery Aneurysm, Mediastinitis, Dementia, and Pneumonia." Michael S. Gelfand, M.D., Allen B. Kaiser, M.D., and W. Andrew Dale, M.D. Reviews of Infectious Diseases, September-October 1989, 11(5):783-788.

20. "Brief Report: Clinical Study of Intravenous and Oral Ciprofloxacin in Complicated Bacterial Infections." Michael S. Gelfand, M.D., Bryan P. Simmons, M.D., Rebecca B. Craft, R.N., and J.T. Grogan, M.T.-A.S.C.P. The American Journal of Medicine, November 30, 1989;87(5A):235S-237S.

21. "Multiple Hepatic Abscesses Caused by Streptococcus Milleri in Association with an Intrauterine Device." Michael S. Gelfand, M.D., Thomas Hodgkiss, M.D., and Bryan P. Simmons, M.D. Reviews of Infectious Diseases, November-December 1989;11(6):983-987.

22. "In Vitro Comparison of Cefoperazone/Sulbactam With Selected Antimicrobial Agents Against 300 Bacteroides Isolates." Michael S. Gelfand, M.D., J.T. Grogan, M.T.-A.S.C.P., and M.H. Haas, M.T. Diagnostic Microbiology and Infectious Diseases, 1989;12:421-428.

23. "Cefamandole versus Cefonicid Prophylaxis in Cardiovascular Surgery: A Prospective Study." Michael S. Gelfand, M.D., et al. Annals of Thoracic Surgery, 1990;49:435-439.

24. "Candidal Meningitis Following Bacterial Meningitis." Michael S. Gelfand, M.D., Z.A. McGee, A.B. Kaiser, et al. Southern Medical Journal, 1990;83:567-570.

25. "Invasive Pulmonary Penicilliosis: Successful Therapy with Amphotericin B." Michael S. Gelfand, M.D., F. Hammond Cole, Jr., M.D., and Reed C. Baskin, M.D. Southern Medical Journal, 1990;83:567-570.

26. "Spinal Arachnoiditis with Cryptococcus Neoformans in a Nonimmunocompromised Child." W.C. Woodall, Tulio E. Bertorini, M.D., B.J. Bakhtian, and Michael S. Gelfand, M.D. Pediatric Neurology, 1990;Vol. 6:206-208.

27. "Characterization of Mechanisms of Resistance to Beta-Lactam Antibiotics in Methicillin-Resistant Strain of Staphylococcus Saprophyticus." C.W. Stratton, Michael S. Gelfand, M.D., et al. Antimicrobial Agents and Chemotherapy, 1990;34:1780-1782.

28. "Multicenter In Vitro Comparison of Piperacillin and Nine Other Antibacterials Against 1,629 Clinical Isolates." Richard N. Greenberg, Michael S. Gelfand, M.D., et al. Clinical Therapeutics, 1990;12:61-70.

29. "Fungal Pseudomeningitis Superimposed on Escherichia Coli Meningitis." Michael S. Gelfand, M.D., P.E. Schoch and B.A. Cunha. Heart and Lung, 1990;19:534-536.

30. "Neurological Complications of Bacterial Endocarditis." Tulio Bertorini, M.D. and Michael S. Gelfand, M.D. Comprehensive Therapy, 1990;16(12):47-55.

31. "Spinal Sepsis Due to Streptococcus Milleri: Two Cases and Review." Michael S. Gelfand, M.D., Bijan J. Bakhtian, M.D., and Bryan P. Simmons, M.D. Reviews of Infectious Diseases, 1991;15:559-63.

32. "Listeria Monocytogenes causing Endovascular Infection." M.Lamothe, B.Simmons, M.Gelfand, P.Schoettle and E.Owen. Southern Medical Journal, 1992;85:193-195.

33. "Tularemia Serology: Differentiating True-Positive and False-Positive Titers." M.S. Gelfand, W.Slade, and I.Abolnik. Infectious Diseases in Clinical Practice, 1992;1:105-108.

34. "Nocardia Otitidiscaviarum (Caviae) Infection in a Heart Transplant Patient Presented as Having a Thigh Abscess (Madura Thigh)." Bryan P. Simmons, M.D., Michael S. Gelfand, M.D., and Glenn D. Roberts, PhD. The Journal of Heart and Lung Transplantation, July/August 1992;Vol.11, Number 4, Part 1:824-826.

35. "Penicillin-Resistant Pneumococcal Vertebral Osteomyelitis." Michael S. Gelfand, M.D., and Kerry O. Cleveland. Clinical Infectious Diseases, 1992;15:746-47.

36. "The Rapid Emergence of Fluoroquinolone-Methicillin-Resistant Staphylococcus aureus Infections in a Community Hospital--An In Vitro Look at Alternative Antimicrobial Agents." Kenneth E. Aldridge, M.D., Michael S. Gelfand, M.D., Denise D. Shiro, M.D., and Neil L. Barg, M.D. Diagnostic Microbiology and Infectious Diseases, 1992;15:601-608.

37. "In Vitro Activity of Various Antimicrobial Agents Against Staphylococcus aureus isolates Including Fluoroquinolone- and Oxacillin-Resistant Strains." Kenneth E. Aldridge, M.D., Ronald N. Jones, M.D., Arthur L. Barry, M.D., and Michael S. Gelfand, M.D. Diagnostic Microbiology and Infectious Diseases, 1992;15:517-521.

38. "Subacute Bacterial Endocarditis Secondary to Streptococcus pneumoniae." Michael S. Gelfand, M.D., and Michael G. Threlkeld, M.D. The American Journal of Medicine, July 1992;93:91-93.

Michael S. Gelfand, M.D., F.A.C.P. 7

39. "A Sequential Study of Intravenous and Oral Fleroxacin in the Treatment of Complicated Urinary Tract Infection." Michael S. Gelfand, M.D., Bryan P. Simmons, M.D., Rebecca B. Craft, B.S.N., Jane Grogan, B.S., Naseem Amarshi, Pharm.D. The American Journal of Medicine, March 1993;94(Suppl.3A):126S-130S.

40. "To the Editor -- The Death Pen." (Letter) Michael S. Gelfand, M.D. and Danny J. Lancaster, M.D. JAMA, September 1993;270:1316.

41. "Blastomycosis in Immunocompromised Patients." Peter G. Pappas, M.D., Michael G. Threlkeld, M.D., Glenn D. Bedsole, M.D., Kerry O. Cleveland, M.D. Michael S. Gelfand, M.D., and William E. Dismukes, M.D. Medicine, 1993;72:311-325.

42. "Listerial Brain Abscess in a Patient with Chronic Lymphocytic Leukemia Treated with Fludarabine." (Letter) Kerry O. Cleveland, M.D. and Michael S. Gelfand, M.D. Clinical Infectious Diseases, October 1993;17:816-817.

43. "Hand Infection and Bacteremia due to Methicillin-Resistant Staphylococcus aureus Following a Clenched-Fist Injury in a Nursing Home Resident." (Letter) Michael S. Gelfand, Clinical Infectious Diseases, March 1994, 18:469.

44. "Plesiomonas Shigelloides Wound Infection and Purulent Tenosynovitis Associated with Catfish-related Injury." Igor Z. Abolnik, Michael S. Gelfand. Infectious Diseases in Clinical Practice, 1994;3:292-294.

45. "Group B Streptococcal Bacteremia Associated with Adenocarcinoma of the Stomach." (Letter) Michael S. Gelfand, John R. Hughey and David D. Sloas. Clinical Infectious Diseases, 1994(August);19:364.

46. "Bone Marrow Granulomas, Fever, Pancytopenia, and Lupus-like Syndrome due to Tocainide." Michael S. Gelfand et al. Southern Medical Journal. August 1994;87:839-841.

47. "Treatment of Skin and Soft-Tissue Infections Utilizing an Outpatient Parenteral Drug Delivery Device: A Multicenter Trial." Donald M. Poretz and the HIAT Study Group. American Journal of Medicine. August 15, 1994;97 (Suppl. 2A):23-27.

48. "Treatment of Serious Infections with Cefotaxime Utilizing an Outpatient Drug Delivery Device: Global Analysis of a Large Scale, Multicenter Trial." Donald M. Poretz and the HIAT Study Group. American Journal of Medicine. August 15, 1994;97 (Suppl.2A);34-32.

49. "Outpatient Antibiotic Therapy for Elderly Patients". Jose V.G. Augel and the HIAT Study Group. American Journal of Medicine. August 15, 1994;97 (Suppl.2A);43-49

50. "Blastomycosis ARDS in Immunocompromised Patients - Three Cases and Review." Michael S. Gelfand et al. Infectious Diseases in Clinical Practice. Nov-Dec 1994;3:441-444.

51. "Adenovirus Parotitis in Patients with AIDS". Michael S. Gelfand, Kerry O. Cleveland, Danny Lancaster, Cathy E. Corbett, and Noel T. Florendo. Clinical Infectious Diseases. 1994;19:1045-8.

52. "Streptococcal Meningitis Complicating Diagnostic Myelography: Three Cases and Review". Michael S. Gelfand, Igor Z. Abolnik. Clinical Infectious Diseases. 1995;20:582-7.

53. "Invasive Staphylococcal Infections Complicating Percutaneous Transluminal Coronary Angioplasty: Three Cases and Review". Kerry O. Cleveland, Michael S. Gelfand. Clinical Infectious Diseases. 1995;21:93-6.

54. "Cefotaxime Twice Daily Versus Ceftriaxone Once Daily - A Randomized Controlled Study in Patients with Serious Infections". B.P. Simmons, M.S. Gelfand, J.Grogan, and B.Craft. Diagnostic Microbiology Infectious Disease. 1995;22:155-157.

55. "In Vitro Killing of Penicillin-Susceptible, -Intermediate, and -Resistant Strains of Streptococcus pneumoniae by Cefotaxime, Ceftriaxone, and Ceftizoxime; A Comparison of Bactericidal and Inhibitory Activity with Achievable CSF Levels. Charles W. Stratton, Kenneth E. Aldridge, and Michael S. Gelfand. Diagnostic Microbiology Infectious Disease 1995;22:35-42.

56. "Rocky Mountain Spotted Fever: Legal Duty to Warn for Noncontagious Diseases" (Letter). MS Gelfand, CB Daniel, L Killebrew. JAMA,1995;274:1586-1587.

57. "Streptococcal Meningitis Complicating Myelography: Report of Additional Cases" (Letter). MS Gelfand and IZ Abolnik. Clinical Infectious Diseases 1996;22:395.

58. "Streptococcal Meningitis as a Complication of Diagnostic Myelography: Medicolegal Aspects". MS Gelfand and DM Cook. Clinical Infectious Diseases 1996;22:130-132.

59. "Peritonitis Due to Penicillium sp in a Patient Receiving Continuous Ambulatory Peritoneal Dialysis". J Fahhoum and MS Gelfand. Southern Medical Journal 1996;89:87-88.

60. "Invasive Staphylococcal Infections Complicating Percutaneous Transluminal Coronary Angioplasty" (Letter). KO Cleveland and MS Gelfand. Clinical Infectious Diseases 1996;22:603.

61. "Infections in the Elderly" Gelfand MS. Anticrobial and Infectious Diseases Newsletter 1995;14:77-79.62. "Complications of Intravenous Gammaglobulin in Neuromuscular and Other Diseases" Bertorini TE, Nance AM,

Homer LH, Greene W, Gelfand MS, Laster JH. Muscle and Nerve 1996;19:388-391.

Michael S. Gelfand, M.D., F.A.C.P. 8

63. "Group B Streptococcal Wound Infections Following Clean Surgical Procedures in Adults" Cleveland KO, Gelfand MS. Infectious Diseases in Clinical Practice 1996;5:558-560.

64. "Fluconazole and Amphotericin B for Cryptococcal Meningitis" Clark AB, Lobo BL, Gelfand MS. Annals of Pharmacotherapy 1996;30:1408-1410.

65. "Candidiasis: Implications for Intensivists and Pulmonologists” Gelfand MS. Seminar in Respiratory and Critical Care Medicine 1997;18:225-234.

66. "Decrease in Candidemia Rates Associated with Empiric Use of Amphotericin B and Fluconazole for Nosocomial Fever of Unknown Origin” Simmons BP, Gelfand MS, Kritchevsky SB, Greene W, Chow S. Infectious Disease in Clinical Practice 1997;6:177-181.

67. "Spontaneous Pyomyositis Due to Staphylococcus epidermidis" (letter) Yates SW, Gelfand MS, Handorf CR. Clinical Infectious Diseases 1997; 24:1016-1017.

68. "Single-Dose Fostomycin Tromethamine: Evaluation in the Treatment of Uncomplicated Urinary Tract Infection” Gelfand MS, Johnson R. Advances in Therapy 1997;14:49-63.

69. "Encephalopathy Due to Capillary Leak Syndrome” Bertorini TE, Gelfand MS, O'Brien TF. Southern Medical Journal 1997;90:1060-1062.

70. "Meningococcal Cellulitis and Sialadenitis" Gelfand MS, Cleveland KO, Campagna C, Zolyomi A. Southern Medical Journal 1998;9:287-288.

71. “Abdominal Pain and Fever – An Unusual Presentation of Meningococcemia”. A.Demeter and M.S.Gelfand. Clinical Infectious Diseases 1999;28:1327.

72. “Nosocomial Fever of Unknown Origin”. I.Abolnik, J.Fahhoum, K.Cleveland, M.Abramson, G.Corey, M.Gelfand, D.Sexton. Infectious Diseases in Clinical Practice 1999;8:396-398.

73. “Ertapenem Once Daily versus Piperacillin-Tazobactam 4 times per Day for Treatment of Complicated Skin and Skin-Structure Infections in Adults: Results of a Prospective, Randomized, Double-Blind Multicenter Study, Donald R Graham et al Clinical Infectious Diseases 2002;34:1460-1468

74. “ West Nile virus infection “ Michael S. Gelfand Postgraduate Medicine 2003 (July);114:31-3875. Fever and neutropenia clinical practice guidelines. Segal BH, Freifeld AG, Baden LR, Brown AE, Casper C, Dubberke

E, Gelfand, MS et al. J Natl Compr Canc Netw 2004;2:390-432.76. "Vancomycin Therapy and The Progression of Methicillin-resistant Staphylococcus Aureus Vertebral Osteomyelitis"

Gelfand M, Cleveland KO. Southern Medical Journal 2004;97:593-59777. “Evolving Infectious Aortitis Caused by Streptococcus Pneumoniae” Goswami R, Cleveland KO, Gelfand MS

Southern Medical Journal 2004;97:1004-100678. “In Support of Dr. Thomas C. Butler” (letter) Kerry O. Cleveland, Michael S. Gelfand Clinical Infectious Diseases

2005;41:107379. “Hematogenous Vertebral Osteomyelitis Due to Staphylococcus aureus in the Adult”. Editorial. Michael S. Gelfand,

Kerry O. Cleveland Southern Medical Journal 2005;98:85380. “Pathological Fracture in Acute Osteomyelitis of Long Bones Secondary to Community-Acquired Methicillin-

Resistant Staphylococcus aureus: Two cases and Review of the Literature”. Michael S. Gelfand, Kerry O. Cleveland, Robert K. Heck, Rekha Goswami. Am J Med Sci 2006;332(6):357-360.

81. “Diarrhea as a Symptom in Bacteremic Pneumococcal Pneumonia”. Kerry O. Cleveland, Michael S. Gelfand Rekha Goswami. Inf Dis Clin Practice 2007;15:1

82. Prevention and treatment of cancer-related infections. Segal BH, Freifeld AG, Baden LR, Brown AE, Casper C, Dubberke E, Gelfand, MS et al. J Natl Compr Canc Netw 2008;6:122-74.

83. “Ethical Consideration for Use of Carbapenems as Treatment for Sepsis Due to Carbapenem-Resistant Bacteria” (letter) Kerry O. Cleveland, Michael S. Gelfand. Journal of Infectious Diseases 2009;199:288-289.

84. A Lacasse, R Odero, MS Gelfand Chlamydia pneumoniae infective endocarditis. J Investig Med 57 (1);340 ( Abstract 140): Jan 2009.

85. A Lacasse, R Odero, MS Gelfand. Pseudomonas aeruginosa skull base osteomyelitis without otitis externa. J Investig Med 57 (1);340 (Abstract 141): Jan 2009

86. O Jones, MS Gelfand KO Cleveland "A Case of Disseminated Histoplasmosis Following Autologous Stem Cell Transplantation for Hodgkin's Lymphoma: an Initial Misdiagnosis With a False-Positive Serum Galactomannan Assay". Accepted for publication: Transpl Infect Dis. 1.2009

87. “ Trichosporon asahii infection in an HIV-positive patient”. (letter). AIDS 2009;23:1027-1033. Odero RO, Lacasse A, Mazumder S, Gelfand M, Cleveland K.

Michael S. Gelfand, M.D., F.A.C.P. 9

88. “Rhabdomyolysis and acute renal failure associated with the co-administration of daptomycin and an HMG-CoA reductase inhibitor” Randy O. Odero; Kerry O. Cleveland; Michael S. Gelfand. Journal of Antimicrobial Chemotherapy 2009; doi: 10.1093/jac/dkp127

89. “Successful Treatment with Doripenem and Tobramycin of Ventriculitis Due to Imipenem- and Meropenem-Resistant Pseudomonas Aeruginosa” Michael S. Gelfand; Kerry O. Cleveland; Shirin A. Mazumder Journal of Antimicrobial Chemotherapy 2009; doi: 10.1093/jac/dkp134

90. "Optic Neuropathy Following Linezolid Use in a Patient with Acute Lymphocytic Leukemia." (letter). Cleveland K.O., Gelfand M.S. Clinical Infectious Diseases. 2009;49:645-646

91. “Community-acquired MRSA and Lemierre Syndrome”. Bilal M., Cleveland K.O.,Gelfand M.S. The American Journal of Medical Sciences 2009;338:326-327

92. “Atypical Skull Base Osteomyelitis: Report of Two Cases” Lacasse A, Odero RO, Gelfand, MS, Cleveland KO. Tennessee Medical Journal April 2010 pg 37-38.

93. “Case Study: Differential Diagnosis of a Patient with Rhomboencephalitis" Mazumder S, Michael M, Gelfand MS. Accepted for publication. Infectious Diseases in Clinical Practice.

94. “Rhodococcus equi Pneumonia in a Patient with Fludarabine-Treated Chronic Lymphocytic Leukemia and CD4 lymphopenia”. Gelfand M, Cleveland K, Brewer S. Accepted for publication. The American J of Medical Sciences

95. “Differential Diagnosis of a Patient with Rhombencephalitis” L. Madison Michael, Shirin A. Mazumder, Michael S. Gelfand Infectious Dis in Clin Pract Accepted for publ. 2011.

96. “Abnormal Positron Emission Tomography Scan due to Undiagnosed Adrenal Histoplasmosis. Michael S. Gelfand, Kerry O. Cleveland, Reed C. Baskin Infect Dis in Clin Pract accept for publ 2011.

97. “Telavancin for The Treatment of Methicillin-Resistant Staphylococcus Aureus Osteomyelitis” J Antimicrob Chemother. doi:10.1093/jac/dkr329 Twilla, J, Gelfand MS, Cleveland K, Usery J. Published online Aug 10, 2011

98. “Successful therapy of treatment-emergent, non-clonal daptomycin non-susceptible Enterococcus faecium infections” S. Travis King, Justin B. Usery, Katherine Holloway, Laura Koeth, Kerry O. Cleveland and Michael S. Gelfand J Antimicrob Chemotherapy doi:10.1093/jac/dkr343 Advance Access Publication August 16 2011

99. “Detection of Vancomycin Levels in Patients Receiving Telavancin but Not Vancomycin” Gelfand, Michael; Cleveland, Kerry; Memon, Kashif Accepted for publication J Antimicrob Chemothery Sept 29, 2011

100."Vancomycin-Resistant Enterococcus (VRE) Bacteremia: “An Evaluation of Treatment with Linezolid or Daptomycin" Twilla J, Finch C, Broyles, J, Gelfand M et al Accepted for publication J Hospital Med October 2011 J Hosp Med. 2012 Mar;7(3):243-8. doi: 10.1002/jhm.994. Epub 2011 Nov 10

101."Brain Abscesses Associated with Right-to-Left Shunts in Adults: Two Cases and Discussion" Memon K, Cleveland K, Gelfand MS. Accepted for publication The Amer J Med of the Sciences Oct 14, 2011 Am J Med Sci. 2012 Apr;343(4):334-6

102."Percutaneous Transluminal Angioplasty in a Patient with Vasospasm Secondary to Staphylococcal Meningitis: Case Report and Discussion" Buechner D., Gelfand, MS, Cleveland KO. J Neurosurgery May 11, 2012 Published July 2012.v 117 pg 103-106

103."Successful Treatment With Doripenem Of Ventriculitis Due To Achromobacter xylosoxidans" Gelfand, MS, Cleveland KO – accepted for publication Quaterly Journal of Medicine – Feb 2012 QJM (2012) doi: 10.1093/qjmed/hcs048 First published online: March 12, 2012. Published 2014;107:923-925. QJM (2014) 107 (11): 923-925.doi: 10.1093/qjmed/hcs048

104.Posaconazole as successful treatment for fungemia due to Cryptococcus albidus in a liver transplant recipient K.O. Cleveland; M.S. Gelfand; V. Rao QJM 2012; doi: 10.1093/qjmed/hcs133

105.Analysis of Outcomes and Risk Factors Associated with Extended-Spectrum β-lactamase-Production in  Bloodstream Infections Author(s): King, Samuel; Azari, Laleh; Twilla, Jennifer; Gelfand, Michael; Cleveland, Kerry; Usery, Justin – submitted for publication

106.“Acute Congestive Heart Failure and Death secondary to Itraconazole Therapy” Gelfand, MS, Cleveland KO. AIDS 2012;26:848-850

107.Family Outbreak of Psittacosis with an Exhumation-Based Diagnosis: Following in the Footsteps of Dr. House Michael S. Gelfand, MD and Kerry O. Cleveland, MD Published online Dec 2012 American Journal of Medical Sciences

108. “The Clinical Significance of Circulating Beta-Glucan in Pediatric Hematology-Oncology Patients with Suspected Invasive Fungal Infections – Literature Review” V. Pirumova and M S Gelfand Hematology ( Russian ) v.3 2012

Michael S. Gelfand, M.D., F.A.C.P. 10

109. “Susceptibility of Streptococcus pyogenes to Trimethoprim-Sulfamethoxazole” Michael S. Gelfand, Kerry O. Cleveland, Daniel C. Ketterer Letter to the Editor – DOI:-10.1128/JCM.03329-12. J.Clin.Microbiol. 2013,51(4):1350.

110. “Vancomycin-induced nephrotoxicity” Letter to the editor. Antimicrob. Agents Chemother. 2013, 57(5):2435. DOI: Michael S. Gelfand and Kerry O. Cleveland

111.“Daptomycin-nonsusceptible enterococcal infections” Kerry O. Cleveland, Michael S. Gelfand – letter to the editor. Infectious Diseases in Clinical Practice. 2013;21:213 DOI: 10.1097/IPC.ObO13e31828875fc

112.“Combination Therapy For Enterococcal Endocarditis” Letter to the Editor. Michael S. Gelfand, Kerry O. Cleveland Published online May 2013 Clinical Infectious Diseases. Published September 1, vol 57:767

113. “ A Comparative analysis of daptomycin and vancomycin in the treatment of vertebral osteomyelitis” Rangaraj Gopi, Cleveland KO, Gelfand, MS – accepted for publication in Infectious Diseases in Clinical Practice

114.“Treatment of Vertebral Osteomyelitis” Letter to the Editor, Michael S. Gelfand, Kerry O. Cleveland. February 2014 pg 299-300. Journal of Infection

115. "Vancomycin-indiced interstitial nephritis superimposed on co-existing renal disease – the importance of renal biopsy:Michael S. Gelfand, Kerry O. Cleveland, Shirin Mazumder. The American Journal of Medical Sciences 2014;4:338-340doi: 10.1097/MAJ.0000000000000240

116. “Common Use of the Empirical Combination of Vancomycin and a Beta-lactam for Staphylococcal Bacteremia” Letter to the Editor Kerry O. Cleveland, Shirin A. Mazumder, Michael S. Gelfand. Epublished Clinical Infectious Diseases January 14, 2014; advance access published Feb 4, 2014

117. “Association of Raoultella Bacteremia with Diseases of the Biliary Tract” Letter to the Editor. Kerry O. Cleveland, Shirin A. Mazumder, Michael S. Gelfand Scandinavian Journal of Infectious Diseases 2014; Early online 1-2.

118. “Minocycline for the Treatment of Community-Acquired Staphylococcus Aureus Infections” Kerry O. Cleveland, Michael S. Gelfand, Shirin A. Mazumder Letter to the Editor. Accepted for Publication International Journal of Antimicrobial Agents 2014;43:385-86 http://dx.doi.org/10.1016/j.ijantimicag.2014.01.010

119. “Neurobrucellosis in a Hunter of Feral Swine” MS Gelfand, KO Cleveland, D Buechner. Accepted for publicationInfectious Diseases in Clinical Practice. February 2014

120.“Bacteriuria in Elderly Individuals” MS Gelfand, KO Cleveland Letter to the Editor. American Journal of Medicine 2014;127:e15. DOI: http://dx.doi.org/10.1016/j.amjmed.2014.04.023

121. “Evaluation of the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia”Justin B. Usery, PharmD, Ngan H. Vo, PharmD, Christopher K. Finch, PharmD, Kerry O. Cleveland, MD,Michael S. Gelfand, MD and Timothy H. Self, PharmD Accepted for publication American Journal of Medical Sciences Oct 2014

122. “Football Lingo in The Medical World” Letter to the Editor. Kerry O. Cleveland, Michael S. Gelfand . American Journal of Medicine 2015;128:e25

123. “Macrolides and the placenta”. Letter to the Editor. Michael S. Gelfand, Kerry O. Cleveland. Accepted for publication in Expert Opinion in Drug Safety. Oct 2014.

124. “Serum-derived Bovine Immunoglobulin/Protein Isolate Should be Considered in Patients with HIV Gut Barrier Dysfunction” Letter to the Editor. Michael S. Gelfand, Bruce P. Burnett. Infection January 2015 DOI 10.1007/s15010-015-0732-7

125.“Confused by Weisella confusa bacteremia” Letter to the Editor. Michael S. Gelfand, Kerry O. Cleveland. Accepted for publication in J Clin Microb Feb 2015.

126.“Mortality in Bacterial Meningitis in the USA” Letter to the Editor. Michael S. Gelfand, Kerry O. Cleveland. Lancet Infect Dis 2015;15:509.

127. Ceftolozane/tazobactam Therapy of Respiratory Infections Due to Multi-Drug Resistant Pseudomonas aeruginosa Michael S. Gelfand; Kerry O. Cleveland Clinical Infectious Diseases 2015;doi: 10.1093/cid/civ411

128. “Association of hyperglycemia with mortality in Staphylococcus aureus bacteremia in community-dwelling older adults: still unclear. Commentary. Michael S. Gelfand, Kerry O. Cleveland . Inf Dis Clin Pract 2015;23:225

129. “Cryptococcus ungullatus meningitis: Case report and review of the literature” Chinelo Animalu, Shirin Mazumder, Kerry Cleveland, Michael S. Gelfand – Amer J Med Sciences 2015;350;421-422.

130. “ Streptococcus pyogenes acute proctosigmoiditis, bacteremia, and death in an adult”. Michael S Gelfand, Kerry O. Cleveland –The American Journal of Medical Sciences 2016;351:120-121

131. “Oral Serum-Derived Bovine Immunoglobulin for Treatment of Infectious Diarrhea due to Norovirus and Cryptosporidiosis in Renal Transplant Patients” Michael S. Gelfand, Kerry O. Cleveland – accepted for publication Inf Dis Clin Pract Nov 2016

Michael S. Gelfand, M.D., F.A.C.P. 11

132.“ Fatal Fulminant Herpes Hepatitis in Pregnancy” Kerry O. Cleveland, Michael S. Gelfand, Kerry O. Cleveland , David M. Cook – submitted for publication

133. "Ceftazidime/Avibactam for Treatment of Pleural Empyema Due to Carbapenem-Resistant Serratia marcescens" Kerry O. Cleveland, Michael S. Gelfand – letter. Infectious Diseases in Clinical Practice 2016;24:128

134.“Dual disseminated fungal infection with Histoplasma capsulatum and Cryptococcus neoformans in patients with AIDS” Michael S. Gelfand, Kerry O. Cleveland – submitted for publication

135.“Reversion from Methicillin Susceptibility to Methicillin Resistance in Staphylococcus aureus” Kerry O. Cleveland, Michael S. Gelfand. Letter. Journal of Infectious Diseases. 2016 doi: 10.1093/infdis/jiw051

136. “Bordetella holmesii bacteremia and endocarditis”. Inyong Hwang Rajesh Kabra, Anthony Holden, Timothy Woods, Michael Gelfand – submitted for publication Annals of Thoracic Surgery

Abstracts:

1. "Clinical Microbiology and Infection Control." The Southern Association for Clinical Microbiology Abstracts, 1985.2. "Clinical Study of Intravenous and Oral Ciprofloxacin in Complicated Bacterial Infections." Ciprofloxacin

Symposium. April 28, 1989. Naples, Florida.3. "Cefepime (CFP) in the Treatment of Infections in Hospitalized Patients." Abstracts of the ASM Annual Meeting-

1989. A-18. New Orleans, LA.4. "Enterobacter sakazakii Bacteremia From Contaminated Infant Formula." Abstracts of the ASM Annual Meeting-

1989. L-17. New Orleans, LA.5. "In Vitro Comparison of Cefoperazone/Sulbactam With Selected Antimicrobials Against 300 Bacteroides Isolates."

Abstracts of the ASM Annual Meeting-1989. A-101. New Orleans, LA.6. “In Vitro Activity of Cefoperazone/Sulbactam Against Cefoperazone - and Amikacin - Resistant Aerobic Gram-

Negative Rods." M.S.Gelfand, M.D., and J.Grogan, B.S. 16th International Congress of Chemotherapy. June 11-16, 1989. Jerusalem, Israel.

7. "Trough Serum Cidal Titers in Elderly Patients Treated with Once Daily Ceftriaxone." M.S. Gelfand, M.D. and J.T. Grogan, B.S. 16th International Congress of Chemotherapy. June 11-16, 1989. Jerusalem, Israel.

8. "Ciprofloxacin-Resistant (CR), Methicillin-Resistant Staphylococcus Aureus." Interscience Conference on Antimicrobial Agents and Chemotherapy. September 17-20, 1989. Houston, Texas.

9. "Cefamandole versus Cefonicid Prophylaxis in Elective Cardiovascular Survey (CVS) - A Randomized Double-Blind Study." Interscience Conference on Antimicrobial Agents and Chemotherapy. September 17-20, 1989. Houston, Texas.

10. "Cefepime vs. Ceftazidime Treatment of Infections in Hospitalized Patients." B.G. Yangco, M.D., Michael S. Gelfand, M.D., et al. American Society for Microbiology Annual Meeting. A-95. May 13-17, 1990. Anaheim, California.

11. "Intravenous Fleroxacin Once Daily Therapy of Miscellaneous Serious Bacterial Infections." Michael S. Gelfand, M.D., Bryan P. Simmons, M.D., Rebecca B. Craft, R.N., N. Amarshi, D. Maladorno, P. Casey, and D. Pizzuti. International Congress for Infectious Diseases. July 15-19, 1990. Montreal, Canada.

12. "A Randomized Study of Two Low-Dose Regimens of Cefpirome (HR-810) in the Treatment of Complicated Urinary Tract Infections." Michael S. Gelfand, M.D., Bryan P. Simmons, M.D., Rebecca B. Craft, R.N., and J. Savarese. International Congress for Infectious Diseases. July 15-19, 1990. Montreal, Canada.

13. "In Vitro Activity of Cefoperazone/Sulbactam, Piperacillin/Tazobactam, Cefepime, Cefpirome, Fleroxacin, and Other Anti-Microbials Against Xanthomonas Maltophilia." Michael S. Gelfand, M.D., and J.T. Grogan, B.S. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) October 21, 1990. Atlanta, Georgia.

14. "Ciprofloxacin-resistant Clinical Isolates of Aerobic Gram-negative Rods Are More Susceptible to Beta-lactam Antibiotics Than Ciprofloxacin-sensitive Controls." M.S. Gelfand, M.D. and J.T. Grogan, B.S. American Society for Microbiology. May 5-9, 1991. Dallas, Texas.

15. "Comparative Activity of Meropenem, Piperacillin/Taxobactam, Cefoperazone/sulbactam and Miscellaneous Other Agents Against Ciprofloxacin, Cefoperazone and/or Amikacin-resistant Gram-negative Rods." M.S. Gelfand, M.D. and J.T. Grogan, B.S. American Society for Microbiology. May 5-9, 1991. Dallas, Texas.

Michael S. Gelfand, M.D., F.A.C.P. 12

16. "Cefotaxime (CTX) Twice Daily vs. Ceftriaxone (CTR) Once Daily: A Randomized, Controlled Study in Serious Infections." B.P. Simmons, M.D., M.S. Gelfand, M.D., J.Grogan, B.S., D.Winters, R.N., and N. Amarshi, Pharm.D. 17th International Congress of Chemotherapy. June 23-28, 1991. Berlin, Federal Republic of Germany.

17. "Cefotaxime Twice Daily vs. Ceftriaxone Once Daily: A Randomized, Controlled Trial in Serious Infections." B.P. Simmons, M.S. Gelfand, J.Grogan, D.Winters, and N. Amarshi. Methodist Hospital. Memphis, Tennessee. Southern Section, American Federation for Clinical Research. January 29, 1992. Hyatt Regency Hotel, New Orleans, Louisiana.

18. "Randomized Double-Blind Study of Teicoplanin and Vancomycin in Gram-Positive Bacteremia and Endocarditis." M.S. Gelfand, B.P. Simmons, M.G. Threlkeld, D.B. Winters, J.T. Grogan, N.Amarshi, M.A. Elsabawy. Methodist Hospital and St. Joseph Hospital, Memphis, Tennessee. Southern Section, American Federation for Clinical Research. January 29, 1992. Hyatt Regency Hotel, New Orleans, Louisiana.

19. "Evaluation of a Rapid Technique for Predicting Antimicrobial Resistance in Mixed Aerobic/Anaerobic Infections." M.Gelfand and J.Grogan - Methodist Hospital, Memphis, Tennessee. Abstract #C-245. American Society for Microbiology, 92nd General Meeting, May 1992, New Orleans, Louisiana.

20. "Multicenter Study of Cefepime in the Treatment of Infections of Urinary Tract, Lower Respiratory Tract, and Skin and Skin Structures." R. Craft, Cefepime Multicenter Study Group. Methodist Hospital, Memphis, Tennessee. Abstract #A-127. American Society for Microbiology, 92nd General Meeting, May 1992, New Orleans, Louisiana.

21. Cefotoxime Twice Daily vs. Ceftriaxone Once Daily: A Randomized Controlled Study in Serious Infections." B.P. Simmons, M.S. Gelfand, J.T.Grogan, D.Winters, N.Amarshi. Methodist Hospital, Memphis, Tennessee. Abstract #A-25. American Society for Microbiology, 92nd General Meeting, May 1992, New Orleans, Louisiana.

22. "In Vitro Activity of Double Beta-Lactam Combinations against Oxacillin-Resistant S.aureus and S.epidermidis." M.Gelfand and J.Grogan. Methodist Hospital, Memphis, Tennessee. Abstract #A-111. American Society for Microbiology, 92nd General Meeting, May 1992, New Orleans, Louisiana.

23. "Empiric Use of Amphotericin B and Fluconazole for Nosocomial Fevers of Unknown Origin (NFUO) Not Responding to Antibacterial Antibiotics (AA)." B.P. Simmons, M.S.Gelfand, D.Gray, W.Greene, and S.Chow. Methodist Hospitals, Memphis, Tennessee. Infectious Diseases Society of America, 1993. Abstract #145.

24. "Ampicillin/Sulbactam versus Cefazolin: A Prospective Randomized Double-Blind Study of a Single Dose Prophylaxis of PEG-Associated Infections." M.S. Gelfand, D.D.Sloas, et al. 33rd ICAAC, New Orleans, Louisiana, October 17-19, 1993. Abstract #537.

25. "Emerging Multiple Resistant Enterococci (MRE) Among Clinical Isolates: Prevalence Data From 97 Medical Centers". R.N.Jones and the Enterococcus Study Group. 33rd ICAAC, New Orleans, Louisiana, October 17-19, 1993. Abstract #1052.

26. Staphylococcal Septic Arthritis Complicating Percutaneous Transluminal Coronary Angioplasty (PTCA)". K.O.Cleveland, M.S.Gelfand, Methodist Central Hospital, Memphis, TN. Infectious Diseases Society of America 1994 Annual Meeting, Orlando, Florida. Abstract #112.

27. "Streptococcal Meningitis Complicating Diagnostic Myelography". M.S.Gelfand, I.Z.Abolnik. Infectious Disease Society of America 1994 Annual Meeting, Orlando, Florida. Abstract #104.

28. "Streptococcal Group B Wound Infections Following Clean Surgical Procedures in Adults." K.O. Cleveland, M.S.Gelfand. Methodist Hospitals of Memphis, Memphis, Tennessee. Infectious Disease Society of America 1995 Annual Meeting, San Francisco, California. Abstract #111.

29. "Fatal Rocky Mountain Spotted Fever (RMSF) in Antibiotic Era". I.Z.Abolnik, K.B.Kirkland, M.S.Gelfand, D.J.Sexton. Duke University Medical Center, Durham, N.C. and Methodist Hospital, Memphis, TN. Infectious Disease Society of American 1995 Annual Meeting, San Francisco, California. Abstract #196.

30. "Comparisons of the In Vitro Activity of DU 6859a. A New Fluoroquinolone, with that of Ciprofloxacin, Ofloxacin, and Other Antimicrobials Against Aerobic Clinical Isolates. K.E.Aldridge, D.Leverne, S.Hahn, D.Ashby, M.Gelfand. LSU Medical Ctr, New Orleans, Louisiana and Methodist Hospitals, Memphis, TN. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. 1995, San Francisco, California. Abstract #F182.

31. "In Vitro Assessment of Ciprofloxacin in Combination with Antipseudomonal Beta-lactam Agents against Pseudomonas Aeruginosa". S.Ainsworth, PHD, M.S.Gelfand, M.D., C.W.Stratton, M.D. Dept. of Veterans Affairs Medical Center, Alexandria, LA, Methodist Hospital, Memphis, TN, Vanderbilt University School of Medicine, Nashville, TN. Meeting of the European Society of Clinical Microbiology and Infectious Disease 1995.

32. "Nosocomial Fever of Unknown Origin (FUO)". IZ Abolnik, KO Cleveland, JS Fahhoum, MA Abramson, GR Corey, MS Gelfand and DJ Sexton. 6th Annual Meeting of the Society of Healthcare Epidemiologists of America. Washington, D.C. 4/21-23/96. Abstract #M18.

Michael S. Gelfand, M.D., F.A.C.P. 13

33. "Cefepime: Comparative in Vitro Activity Against Common Strains of Enterobacteriaceae Producing Beta-lactamase" Aldridge KE, LaVerne D, Gelfand MS. 7th International Congress for Infectious Diseases, Hong Kong, June 10-13, 1996.

34. "Outpatient Intravenous Antibiotic Therapy of Serious Bacterial Infections with Experimental Antibiotics” Winters D, Gelfand MS, Simmons BP, Methodist Hospitals Interscience Conference on Antimicrobial Agents and Chemotherapy 1996. New Orleans, LA.

35. "Comparative Activity of Cefepime against Respiratory Pathogens of P.Aeruginosa, A. Baumanii, and enterics from ICU patients." Aldridge KE, Ashcraft D, Gelfand MS. 8th European Congress of Clinical Microbiology and Infectious Diseases. Lausanne, Switzerland, May 25-28, 1997.

36. "Pontine abscess as a presentation of systemic infection with the fungus Exophiala jeanselmei" O'Brien TF, Handorf CR, Gelfand MS, Brophy JD. Journal of Neuropathology and Experimental Neurology 1998;57 (5); 480.

37. “Comparison of In Vitro Activity of Piperacillin/tazobactam (P/T), Ticarcillin/clavulanate (T/C), Ampicillin/sulbactam (A/S), Ceftriaxone (CTR), Ofloxacin (OFL), and Imipenem (IMP) Against Nosocomial Isolates.” Aldridge KE, Gelfand M, Davis S, Ashcraft D. 10 th European Congress of Clinical Microbiology and Infectious Diseases. Stockholm, Sweden, May 28-31, 2000.

38. “Comparative In Vitro Activity of MK-0826 (L-749,345), a New Carbapenem, Against Nosocomial Isolates of Enterobacteriaceae.” Aldridge KE, Ashcraft D, Davis S, Gelfand M. 10th European Congress of Clinical Microbiology and Infectious Diseases. Stockholm, Sweden. May 28-31, 2000.

39. “Comparative In Vitro Activity of Cefepime, With Other Antimicrobials Against Nosocomial Isolates of Enterobacteriaceae P. aeruginosa, and Acinetobacter. Gelfand M, Aldridge KE, Davis S, Ashcraft D. 10th European Congress of Clinical Microbiology and Infectious Diseases. Stockholm, Sweden. May 28-31, 2000.

40. “Increased cross-resistance to antimicrobials among the Bacteroides fragilis group from blood using clindamycin and cefoxitin as phenotypic markers” K. Aldridge and M. Gelfand 12 th European Congress of Clinical Microbiology and Infectious Diseases Milan, Italy 21-24 April 2002

41. “Prognostic Significance of Serologic Testing in West Nile Virus Meningoencephalitis”. Dieringer NJ, Gelfand MS, Ward J, Quinn RP, Shorr RI. The Society for General Internal Medicine, Southern Regional Meeting; New Orleans, LA; Febr 2003

42. A Lacasse, R Odero, MS Gelfand Chlamydia pneumoniae infective endocarditis. J Investig Med 57 (1);340 ( Abstract 140): Jan 2009.

43. A Lacasse, R Odero, MS Gelfand. Pseudomonas aeruginosa skull base osteomyelitis without otitis externa. J Investig Med 57 (1);340 (Abstract 141): Jan 2009

44. J.D.Twilla, J.E.Broyles,M.S.Gelfand,C.K.Finch,J.B.Usery,J.D.Hudson “Use of Gram-Positive Therapy for the Treatment of Vancomycin-resistant Enterococcus (VRE) Bacteremia ICAAC, Boston, MA Sept 13, 2010

45. Accepted for presentation Chest 2011 meeting Oct 22-26, 2011 Honolulu, Hawaii “ Invasive aspergillosis in H1N1 influenza A pneumonia” Law, P., Yataco, J., Gelfand, MS.,Nasser, W.

46. Nwanguma, V, Gelfand, MS “Usefulness Of Serum Procalcitonin In The Workup Of Febrile Patients After Acute Cns Injury Feb 10, 2012. Southern Regional Meeting. New Orleans, LA. Abstract published in J Invest Med Jan 2012

47. Usefulness of Serum Procalcitonin in the Workup of Febrile Patients after Acute Central Nervous System Injury Victor Nwanguma, MD, Hosam Mousselli, MD, Kerry Cleveland, MD. FACP, Michael Gelfand, MD – IDSA 2012 San Diego, CA

48. Retrospective comparison of doripenem and cefepime in the empiric treatment of adult patients with febrile neutropenia Kashif Memon, M.D., Kerry Cleveland, MD, FACP, Michael Gelfand, MD, Gopikishan Rangaraj, MD and Wonsuk Yoo, Ph.D. – IDSA 2012 San Diego

49. “Acremonium – associated CLABSI in a multiple myeloma patient: pitfalls in diagnosis – a rare case report" – Dan Ketterer, Michael Gelfand PRESENTED 2012 ASCP meeting, Boston, MA

50. “Oral Serum Derived Bovine Immunoglobulin for Treatment of Infectious Diarrhea due to Norovirus and Cryptosporidiosis in Organ Transplant Patients” Gelfand MS, Cleveland KO, Talwar M. Poster presentation. Microbe 2016, Boston, MA 6/16-20/2016

51. “Dual disseminated fungal infection with Histoplasma capsulatum and Cryptococcus neoformans in patients with AIDS” Michael S. Gelfand, Kerry O. Cleveland . ID Week 2016, New Orleans, LA. 10/26-10/30/2016

52. “Bordetella holmesii bacteremia and endocarditis”. Inyong Hwang Rajesh Kabra, Anthony Holden, Timothy Woods, Michael Gelfand – submitted to Heart Rhythm 2017

Book Chapter:

Michael S. Gelfand, M.D., F.A.C.P. 14

1. Diagnostic Procedures for Bacterial Infections . 7th Edition. American Public Health Association, 1988. "Tularemia," pp 581-587.

2. "Hospital Epidemiology and Infection Control." C. Glen Mayhall (ed.) 1995. First Ed. Williams and Wilkins. "Uncommon Causes of Nosocomial Infections", pp 472-483.

3. Conn’s Current Therapy 2002. Chapters “Blastomycosis” and “Brucellosis”.

Electronic Book Chapters:

1. "Epidemiology and Pathogenesis of Listeria monocytogenes Infection" UpToDate CD-ROM textbook, October 30, 1997 with annual review and update. www.uptodateinc.com.

2. "Clinical Manifestations and Treatment of Listeria monocytogenes Infection" UpToDate CD-ROM textbook, January 12, 1998 with annual review and update. www.uptodateinc.com.

3. “Tularemia”. eMedicine, December 10, 2000 www.emedicine.com. Cleveland KO, Gelfand M, Raugi GJ. Tularemia. eMedicine from WebMD. Updated June 30, 2013. Available at: http://www.emedicine.com/med/topic2326.htm.

4. “Cardiobacterium” eMedicine, June 2006. Updates June 2013. Cleveland KO, Dorsainvil PA, Cunha BA, Gelfand MS www.emedicine.com

5. Cleveland KO, Dorsainvil PA, Cunha BA, Gelfand M. Cardiobacterium. eMedicine from WebMD. Updated February 03, 2009. Available at: http://www.emedicine.com/med/topic284.htm .

6. “Pasteurella multocida infections” eMedicine accepted for publication July 2008. Updates June 2012. Alex Lacasse, Gelfand MS Lacasse A, Gelfand M, Lafeber T, Cantey JR. Pasteurella Multocida Infection. eMedicine from WebMD. Updated January 21, 2009. Available at: http://www.emedicine.com/med/topic1764.htm.

7. “Mycobacterium marinum infections” eMedicine accepted for publication July 2008 . Updates June 2012. Alex Lacasse, Gelfand MS Lacasse A, Gelfand M, Kiel RJ. Mycobacterium Marinum. eMedicine from WebMD. Updated January 16, 2009. Available at: http://www.emedicine.com/med/topic1538.htm.

Book Review:

"The Principles and Management of Surgical Infections." John M. Davis and G.Tom Shires (ed.) J.B. Lippincott Co., Philadelphia ASM News, February, 1991, p.96.

Article Review:

The Journal of Rheumatology. December 1991, (Pyomyositis - 8 cases and Review of the Literature). Reviewer for Clinical Infectious Diseases. Reviewer for the Annals of Internal Medicine Reviewer for Southern Medical Journal Reviewer for Mayo Clinics Proceedings Reviewer for the American Journal of Medical Sciences Reviewer for Infection Control and Healthcare Epidemiology Reviewer for European Journal of Clinical Microbiology and Infectious Diseases ( S. constellatus bacteremia

J. Gomez Cerezo et al) – 12/2006 Reviewer for Journal of Infection 2/2008 Therapy of MRSA vertebral osteo Musher paper Reviewer for Infections in Medicine 6/2008 “Infections in Solid Organ Transplantation – Review” Reviewer for Clinical Infectious Diseases 8/2008 “Clinical importance of purulence among methicillin resistant

S.aureus skin and soft tissue infections” Crawford S E et al. Reviewer for Infections in Medicine 9/08 “Pharmacotherapeutic Strategies for Managing CA-MRSA

Infections” Reviewer for Annals of Internal Medicine 5/09 “Recognition, Diagnosis and Treatment of Histoplasmosis

Complicating Tumor Necrosis Factor Blocker Therapy” Reviewer for New England Journal of Medicine 12/27/2012 “ Multistate Outbreak of Listeria Monocytogenes

Infections Associated with Whole Cantaloupe, 2011” Jeffrey McCollum et al Reviewer for Medicine (Baltimore) – 6/2014 “Listeria monocytogenes-associated biliary tract infections” Reviewer for Medicine (Baltimore) – 7/2014 “ Health-care hematogenous vertebral osteomyelitis” Reviewer for Medicine (Baltimore) – 11/2015 “Pneumococcal spontaneous bacterial peritonitis”

Michael S. Gelfand, M.D., F.A.C.P. 15

Review for Clinical Infectious Diseases – 6/2016 “Epidural Abscess Experience at a Medical Center” Review for the Am J Med Scienc -11/16/2016 “Nontyphoidal Salmonella Emphysematous Osteomyelitis” Review for Clin Infect Dis – 12/16/2016 “The Not-So-Good Prognosis of Streptococcal Peri-prosthetic Joint

Infection Managed by Implant Retention: The Results of a Large Multicenter Study”

Fellows Trained Loraine Achebe 2014- Chinelo Animalu 2013- Karim Mina 2013-

Fysal Al Baalbaki 2012-Tina Agbaosi 2012 -Andrew Todd 2011 - 2013Daniel Ketterer 2011-2013Victor NwangumaKashif MemonGopikrishnan Rangaraj, M.D.Hosam Mousselli, M.D.Scott Bartell, M.D.Shirin Mazumder, M.D.Alexandre Lacasse, M.D.Randy Odero, M.D.Bret Barrett, M.D.Victor Farah, M.D.Elwaleed Ahmed, M.D.Jackline Delyaei, M.D.Susan C. Brewer, M.D.Rekha Goswami, M.D.Karl Damiani, M.D.

Clinical Studies:

Randomized study of pseudomonas infection therapy with Moxalactam/Tobramycin or Ticarcillin/Tobramycin. 1979-1980.

Treatment of bacterial infections with Ticarcillin/Clavulanic acid. 1982. Empiric therapy of bacterial infections in granulocytopenic patients with Ticarcillin/Clavulanic Acid or Piperacillin/Tobramycin Combinations. 1982.

Cefoperazone therapy of bacterial infections. 1983. Imipenem Therapy of Pseudomonas aeruginosa Infections. 1985. Effect of Amikacin therapy on susceptibility of gram-negative aerobes to Gentamicin, Tobramycin, and

Amikacin. Phase II study of BMY-28142 (Cefepime)-A fourth generation cephalosporin in the treatment of UTIs, lower respiratory and soft tissue infections. (47 patients).

Intravenous Ciprofloxacin Therapy of serious aerobic gram-negative infections. (50 patients). Antibiotic prophylaxis in cardiac surgery (400 patients. Cefamandole vs. Cefonicid). Cefpirome (HR-810) Therapy of UTIs. Cefepime vs. Ceftazidime Therapy of Soft Tissue Infections. Intravenous Fleroxacin Therapy of Bacterial Infections. Cefotaxime vs. Ceftriazone Therapy of Bacterial Infections. Teichoplanin vs. Vancomycin in gram-positive bacteremia. In progress. Cefepime Therapy of Complicated Nosocomial Infections. Fleroxacin IV/PO Study of Complicated UTIs. Fluconazole/Ampho B Study of Candidemia. Cefotaxime Outpatient IV Pump Study. Teicoplanin vs. Ceftriaxone in Soft Tissue Infections. In progress. Cefepime vs. Ceftazidime study of gram-negative Bacteremia. In progress. Liposomal Ampho B Study. In progress. Pentoxyfilline study of Ampho B Nephrotoxicity prevention. In progress.

Michael S. Gelfand, M.D., F.A.C.P. 16

Percutaneous endoscopic gastrostomy antibiotic prophylaxis study of cefazolin versus ampicillin/sulbactam. Imipenem versus Meropenem in nosocomial pneumonia. G-CSF versus placebo in nosocomial pneumonia. Fluconazole versus placebo in candiduria. FK037 in soft tissue and urinary tract infections. Centoxin (H1A1) vs. placebo study in septic shock. E5 Monoclonal antibody versus placebo in septic shock. Piperacillin/Tazobactam vs. Imipenem in Abdominal Infections. Trovafloxacin (CP-99,219) Study of Nosocomial Pneumonia. Trovafloxacin (CP-99,219) Study of Uncomplicated Skin and Soft Tissue Infections. Trovafloxacin (CP-99,219) Study of Complicated Skin and Soft Tissue Infections. Synercid Study of Nosocomial Gram Positive Pneumonia. Synercid Study of Complicated Soft Tissue Infections. Phase III Pharmacokinetic Study for Determination of Plasma Levels of Synercid. Synercid v. Standard Therapy in Complicated Gram Positive Skin-structure Infections. ZAGAM (sparfloxacin) vs. BIAXIN (clarithromycin) in treatment of CAP. Fluconazole in Febrile ICU Patients at Risk for Fungal Infections. (CytoTab) Affinity Purified Ovine Derived Anti TNF in Sepsis Syndrome. Ampicillin/Sulbactam Treatment of Community Acquired Pneumonia. Open Study of Synercid for Emergency Use. Azithromycin for Treatment of Community Acquired Pneumonia. Clinafloxacin v. Primaxin for Abdominal Infections. Intravenous azithromycin followed by oral azithromycin in the treatment of hospitalized patients with community-

acquired pneumonia. A multicenter open trial. Treatment of skin/soft tissue infections using intravenous and oral U-100766 (an oxazolidinone)--comparison of

two dosing groups. A randomized, multicenter, third party blinded trial comparing trovafloxacin with amoxicillin/clavulanate

(Augmentin) with or without erythromycin for the treatment of community-acquired pneumonia. Oxazolidinone in the treatment of community acquired S.pneumonia pneumonia: An open label, dose

comparative phase II study of intravenous therapy with optional oral continuation. A randomized, double-blind, multicenter trial comparing 10 days of oral therapy with Trovafloxacin-CP-99,219

(200 mg once daily) and 14 days of oral clarithromycin (500 mg BID) for the treatment of acute sinusitis. An open randomized comparative multicenter study of the efficacy, safety and toleration of voriconazole versus

amphotericin B in the treatment of acute invasive aspergillosis in immunocompromised patients. Synercid versus vancomycin or nafcillin in the treatment of catheter-related bacteremia due to staphylococcal

infections. A randomized third party blinded trial comparing trovafloxacin vs.ciprofloxacin plus clindamycin for outpatient

diabetic foot infections. Open study of gram positive bacteremia treated with IV linezolid therapy followed by oral therapy. Multicenter nonrandomized trial of meropenem for the treatment of hospital acquired pneumonia. Blinded therapy with linezolid IV/PO vs. Rocephin followed by cefpodoxime proxetil. Open label noncomparative study of voriconazole in the treatment of primary-secondary fungal infections. Double-blind randomized MK-0826 vs piperacillin/tazobactam in the treatment of complicated skin infections. Blinded, randomized study of synercid vs standard therapy (vancomycin or nafcillin) for the treatment of

osteomyelitis due to gram-positive infections. Linezolid for the treatment of vancomycin-resistant enterococca infections: a double-blind trial comparing 600

mg of linezolid every 12 hours with 200 mg of linezolid every 12 hours. Randomized, double-blind comparative phase II study of the safety and efficacy of ziracin vs vancomycin in the

treatment of serious gram-positive infections. A multicenter, randomized, open-label trial of MERREM I.V. (meropenem, ICI 194,660) and PRIMAXIN I.V.

(imipenem-cilastatin) for the treatment of community-acquired bacterial pneumonia. Open label, comparative, randomized, multicenter phase II study of intravenous treatment of synercid 7.5 mg/kg q

8h vs standard therapy in the treatment of hospitalized patients with nosocomial pneumonia due, at least in part, to gram-positive cocci.

Michael S. Gelfand, M.D., F.A.C.P. 17

Randomized, double-blind, comparative study of the efficacy and safety of synercid monotherapy regimens and synercid in combination with ampicillin in the treatment of infections caused by vancomycin-resistant Enterococcus faecium (VREF).

Open study of Synercid for emergency use (infections due to resistant bacteria, treatment failure of treatment intolerant patients).

Randomized, double-blind, placebo controlled trial of the presumptive use of fluconazole in febrile intensive care patients at risk for fungal infections.

Randomized, double-blind comparative multicenter study of fluconazole plus Ampho B vs fluconazole plus placebo in the treatment of candidemia and its consequences in non-neutropenic patients.

Randomized, multicenter, third party blinded trial comparing Trovofloxacin with Amoxicillin/Clavulante (Augmentin with or without Erythromycin for the treatment of community acquired pneumonia.

Randomized, third party blinded trial of comparing Trovafloxacin vs Cipro plus Cleocinf or outpatient diabetic foot infections.

Open study of gram positive bacteremia. Treated with IVAB Linezolid therapy followed by oral therapy. Blinded therapy with Linezolid IV/PO vs Rocephin followed by Cefpodoxime Proxetil. Randomized placebo controlled trial of CytoTab vs Albumin in sepsis syndrome. Open randomized comparative multicenter study of the efficacy, safety and toleration of Voriconazole vs

Amphotericin B in the treatment of acute invasive aspergillosis in immunocompromixed patients. Open label non-comparative study of Voriconazole in the treatment of primary/secondary invasive fungal

infections. Nonrandomized trial of IV merrem for HAP. Open label randomized study of Synercid vs Vancomycin or Nafcillin in the treatment of central venous catheter

infections. Randomized, double-blind, comparative study of the efficacy and safety of Synercid monotherapy regimens and

Synercid in combination with ampicillin in the treatment of infection caused by vancomycin-resistant enterococcus faecium (VREF).

Randomized to Vancomycin/Nafcillin/Synercid for osteomyelitis treatment. Blinded. Open randomized comparative multi-center study of the efficacy, safety and toleration of voriconazole vs

amphotericin B in the treatment of acute invasive aspergillosis in immunocompromised patients. Synercid vs Vanc/Nafcillin in the treatment of catheter-related bacteremia due to staphylococcal infections. Randomized, open-label, comparative multicenter study of voriconizole vs conventional Amphotericin B followed

by Fluconazole in the treatment of candidemia in non-neutropenic subjects. Multicenter, double-blind, placebo controlled, randomized, phase 3 study of tifacogin [recombinant tissue factor

pathway inhibitor (rTFPI/SC-59735)] in severe sepsis. Randomized, open-label, comparative study of Zosyn (piperacillin/tazobactam) to Levaquin (levofloxacin) for the

treatment of pneumonia acquired in a long-term care or rehabilitation facility. Linezolid (PNU-100766) given intravenously or orally for compassionate use in patients with significant resistant

bacterial infections. Randomized, double-blind study of GT160-246 vs. Vancomycin in patients with C.difficile-associated diarrhea. A phase 3, multicenter, randomized, open-label, comparative study of daptomycin versus conventional therapy in

the treatment of infective endocarditis or bacteremia with Staphylococcus aureus A study of the safety and efficacy of the use of moxifloxacin in elderly patients for the treatment of CAP Dalbavancin versus vancomycin in skin and soft tissue infections with MRSA Doripenem versus Levofloxacin in complicated lower urinary tract infections Linezolid versus standard therapy in catheter-related Gram-positive bacteremia Tigecycline versus linezolid or vancomycin in VRE/MRSA serious infections Tigecycline in the treatment of resistant GNR infections (Enterobacter, Acinetobacter, Klebsiella) Phase 3, Randomized, Investigator-Blind, Multi-Center Study to evaluate efficacy and safety of intravenous

Iclaprim versus intravenous Linezolid in Complicated Skin and Skin Structure Infections (Assist 2 Arpida AG) Phase 3, randomized, investigator-blinded, multi-center study to evaluate efficacy and safety of intravenous

iclaprim versus intravenous linezolid in complicated skin and skin structure infections (ASSIST 1 Arpida AG) A multinational-multicenter, double-blind, randomized, parallel group study to compare the safety and efficacy

of 200 mg PAR-101 taken q12H with 125 mg vancomycin taken q6H for ten days in subjects with Clostridium difficile-associated diarrhea

Michael S. Gelfand, M.D., F.A.C.P. 18

Phase 4, open-label pilot study to evaluate the combination of voriconazole and anidulafungin for the treatment of subjects with proven or probable invasive aspergillosis who are intolerant of polyene treatment (Pfizer)

A prospective, multicenter, randomized, evaluator-blinded, comparator-controlled study to describe the safety and efficacy of daptomycin for the treatment of complicated skin and skin structure infections (cSSSI) and Staphylococcus aureus bacteremia among patients with moderate or severe renal impairment (DAP-RENSE-08-05)

PROCEED: A phase 3, multicenter, randomized, double blind, active controlled study to evaluate the efficacy and safety of IV and oral delafloxacin compared to with vancomycin + aztreonam in patients with acute bacterial skin structure infections ( sub-investigator )

In Vitro Studies:

Susceptibility of Clinical Isolates to Ampicillin/Sulbactam. Susceptibility of 100 isolates of Bacteroides fragilis to 10 Antibiotics. Susceptibility of 730 clinical isolates to Piperacillin and 8 other antibiotics. Cefoperazone/Sulbactam

susceptibility study. Includes 300 strains of bacteroides and 50 strains of Cefoperazone-resistant GNRs. This study also involved a performance of killing curves of selected microorganisms.

Through serum cidal titers of Ceftriaxone-treated elderly patients against a panel of aerobic bacteria. 15 patients. Anaerobic agar screening study. Comparative study of Bacteroides isolates from Methodist and University of Tennessee clinical laboratories. Ciprofloxacin Resistance in MRSA. X-maltophilia - Bactericidal Activity of New Antibiotics and Combinations. Trough Serum Cidal Titers of Cefonicid - Treated Elderly Patients. Serum Bactericidal Activity in Ampicillin/Sulbactam Treated Patients Against MRSA. Timentin Antistaphylococcal in Vitro Activity (Serum and Killing Curves). Meropenem (SM7338) Activity Against Cipro Resistant Gram-negative Rods. Retrospective and Prospective Study of Imipenem Resistance in Aerobic Gram-negative Rods. Double Beta-lactam in Vitro Activity Against MRSA and MRSE. Anaerobic Agar screening study with Ampicillin/Sulbactam and Cefoperazone/Sulbactam. Anaerobic Susceptibility of ICU and Oncology Isolates.

Presentations:

Advances in Medicine--A Multi-Specialty Conference for Physicians, Honolulu, Hawaii, November 26-December 3, 1983: "Septic Shock," "Medical and Surgical Oncologic Emergencies," "Infectious Diarrhea," "Sexually Transmitted Diseases," "New Antibiotics."

Infectious Disease Symposium, Baptist Memorial Hospital, Memphis, Tennessee, May 1984: "Urinary Tract Infections."

University of Tennessee Family Practice: "Aids," "Herpes." Fourth Annual Symposium in Infectious Diseases, Cypress Gardens, Florida, September 14-15, 1984: "Early

Empiric Therapy." Medical Update (Diabetes, Antibiotics, Hypertension, Cardiology, Dermatology) Meridian, Mississippi,

September 20, 1984: "Update in Recent Developments in Antimicrobial Therapy." Clinical Microbiology Review, Memphis, Tennessee, September 27-28, 1984: "Methicillin-Resistant

Staphylococci: Clinical Features, Epidemiology, Control," "Expanded-Spectrum Penicillins and Cephalosporins: Clinical Applications, Cost Controls."

Infection Control Seminar, St. Francis Hospital, Roslyn, New York, October 18, 1984: "Bacterial Pneumonias."

Susceptibility Testing in the 80's--Workshop Program, Vanderbilt University, Nashville, Tennessee, August 23, 1985: "Selection of Antibiotics for Susceptibility Testing in the Clinical Laboratory."

The Southern Association for Clinical Microbiology, Second Annual Meeting. Peabody Hotel, Memphis, Tennessee, September 16-18, 1985: "Infection Control and the Clinical Microbiology Laboratory."

Clinical Microbiology Reviews, Peabody Hotel, Memphis, Tennessee, September 19-20, 1985: "Cost-Effectiveness in the Selection of Antibiotics."

Michael S. Gelfand, M.D., F.A.C.P. 19

University of Tennessee, Infectious Disease Symposium, Gatlinburg, Tennessee, October 14, 1985: "Immunizations in Adults."

Baptist Memorial Hospital, Memphis, Tennessee, Infectious Disease Symposium, October 25, 1985: "Sexually Transmitted Diseases."

University of Tennessee, Memphis, Tennessee, Department of Medicine Grand Rounds, February 5, 1986: "Histoplasmosis."

University of Alabama School of Medicine, Birmingham, Alabama, March 20, 1986: "Yerzinia Enterocolitica" Baptist Medical Center, Birmingham, Alabama, March 20, 1986: "Mechanisms of Antibiotic Resistance." Tennessee Society for Medical Technology, Tennessee State Society of American Medical Technologists,

Spring Meeting, Memphis, Tennessee, May 7-9, 1986: "Clinical Significance of Non-Enteric Gram Negative Bacilli," "New Antibiotics."

American Society of Clinical, Pathologists, Decisions in Microbiology, New Orleans, Louisiana, June 6, 1986: "Update on Antibiotics for the Microbiology Laboratory."

American Society of Clinical Pathologists, Decisions in Microbiology, New Orleans, Louisiana, June 10, 1986: "Advanced Techniques in Microbiology."

New Pathogens and the Clinical Microbiology Laboratory Workshop. Nashville, Tennessee, August 15, 1986: "AIDS-Associated Infections."

Resistant Staphylococci, University of Tennessee, Memphis, Tennessee, September 19, 1986: "Treatment of Staphylococcal Infections."

Infectious Disease - 1986, Baptist Memorial Hospital, Memphis, Tennessee, November 1, 1986: "Sexually-Transmitted Diseases."

Advances in Medicine--A Multi-Specialty Conference for Physicians, Kauai, Hawaii, November 8-15, 1986: "Newer Antibiotics," "AIDS Update."

Current Topics in Infectious Diseases for the Practitioner, University of California, San Francisco, California, February 18, 1987: "Antibiotics in the 80's."

Resistant Staphylococci: Concern of the Eighties, Wild Dunes Beach & Racquet Club, Charleston, South Carolina, February 28, 1987: "Current Therapies of Clinical, Staphylococcal Infections."

Tennessee Society of Hospital Pharmacists, 17th Annual Meeting, Nashville, Tennessee, March 21, 1987: "Considerations in Selecting Appropriate Antibiotics."

University of Tennessee, 20th Annual Review Course for the Family Physician, Memphis, Tennessee, March 24, 1987: "Immunization in Adults."

Smoky Mountain Infectious Disease Conference, Gatlinburg, Tennessee, April 13, 1987: "Infections in the Immunocompromised Patient."

ASCP Regional Course, April 28, 1987: "Decisions in Microbiology," "Sentinel Microorganisms," "Advanced Techniques in Microbiology," "Update on Antibiotics for the Microbiology Laboratory."

Infections in the Elderly Symposium, Tulsa, Oklahoma, May 13, 1987: "Infectious Complications in the Geriatric Patient...Emphasis on Pharmacokinetics in Antibiotic Selection," "Lower Respiratory Tract."

Respiratory Tract Infections--From Coughs to Catastrophes Symposium, Memphis, Tennessee, May 20, 1987: "New Agents and Approaches to Pneumonia: Experience from a Community Hospital."

University of Tennessee Neurology, Grand Rounds, June 10, 1987: "Antibiotics in CNS Infections." AIDS and the Microbiology Laboratory, Nashville State Technical Institute, Nashville, Tennessee, July 10,

1987: "Infectious Complications." Infectious Diseases Update, HCA Center for Research and Education and The Tennessee Academy of Family

Physicians, August 15, 1987: "Update on Pneumonia," "AIDS Perspectives," "Therapy of AIDS-Related Infections," "Prospects for Therapy and Vaccine."

Medicine in the 1990's, Methodist Hospital of Memphis, Naples, Florida, September 24-27, 1987: "Future of Antimicrobial Chemotherapy," "DNA Probes."

Infectious Diseases in the Elderly, Tampa, Florida, November 4, 1987: "Skin and Soft Tissue Infections." University of Tennessee, Sophomore Medical Students, Microbiology Course, Memphis, Tennessee, December

10, 1987: "Microbiology of Respiratory Infections." University of Tennessee, Department of Neurology, Memphis, Tennessee, December 30, 1987: "Cryptococcal

Meningitis." National Interactive Ciprofloxacin, Video Teleconference Regional Moderator, Memphis, Tennessee, February

24, 1988.

Michael S. Gelfand, M.D., F.A.C.P. 20

American Society of Clinical Pathology Regional CME Meeting on Clinical Microbiology, San Antonio, Texas, February 25-26, 1988: "DNA Probes," "Sentinel Microorganisms," "Antibiotics in Clinical Microbiology."

Regional Ciprofloxacin Symposium, Minneapolis, Minnesota, March 22, 1988. Speaker, Regional Ciprofloxacin Symposium, Memphis, TN April 5, 1988. Moderator, Regional

Ciprofloxacin Symposium, Memphis, TN April 6, 1988, Speaker. University of Tennessee, Internal Medicine Residents, Memphis, Tennessee, April 28, 1988: "Clinical

Microbiology Update." Florida Infectious Disease Retreat, Tampa, Florida, May 21, 1988: "Update on Bacterial Resistance." University of South Florida School of Medicine, Infectious Diseases Board Review, Part I & Part II, Tampa,

Florida, May 24 & June 14, 1988. Meharry Medical College, Infectious Disease Forum, Nashville, Tennessee, May 26, 1988: "Infections in the

Elderly." University of Alabama School of Medicine, Division of Infectious Disease, Birmingham, Alabama, February

16, 1989: "Anaerobic Infections." Louisiana State University, School of Medicine, Charity Hospital, New Orleans, Louisiana, February 17, 1989:

Medicine Grand Rounds, "Clinical Microbiology Vignettes." ASCP Educational Course, San Diego, California, March 2-3, 1989: "Decision in Microbiology," "Update on

Antibiotics for the Microbiology Laboratory," "Advanced Techniques in Microbiology," "Sentinel Microorganisms."

Nosocomial Infections: Management Strategies for the 90's, Vancouver, British Columbia, August 11-13, 1989: "Empiric Antibiotic Therapy for the ICU Patient."

Internal Medicine Grand Rounds, University of Tennessee School of Medicine, Memphis, Tennessee, August 30, 1989: "Antibiotic Resistance."

Nosocomial Infections: Management Strategies for the 90's, Marriott's Grand Hotel Point Clear, Alabama, November 5, 1989: "Empiric Antibiotic Therapy for the ICU Patient."

Advances in Medicine--A Multi-Specialty Conference for Physicians, Methodist Hospitals of Memphis and The University of Tennessee, College of Medicine, Hamilton, Bermuda, November 7, 1989: "New Antibiotics--Order Out of Chaos" November 8, 1989, "Pneumonia--New Agents and Therapeutic Approaches."

Symposium on the Management of Respiratory Infections, Los Angeles, California, January 20, 1990: "Use of Oral Antibiotics for Treatment of Respiratory Infections."

Practicing Family Medicine in the 1990's, Memphis, Tennessee, January 27, 1990: "Antibiotics - Order Out of Chaos."

Decisions on Microbiology ASCP Course, Tampa, Florida, February 12-16, 1990: "Update on Antibiotics for the Microbiology Laboratory," "Advanced Techniques in Microbiology," "Sentinel Microorganisms."

Tenth Annual Geriatrics Conference, Callaway Gardens, Pine Mountain, Georgia, April 11, 1990: "Mechanisms of Antibiotic Actions and Resistance in the Elderly."

Annual Meeting of the American Society for Microbiology Symposium on Rapid and Molecular Diagnostic Techniques in Hospital Epidemiology, Anaheim, California, May 14, 1990: "Areas of Need: Where Rapid Techniques are Needed to Facilitate Prevention and Early Treatment of Nosocomial Infections."

The Tenth Annual Intensive Internal Medicine Review, Southfield, Michigan, May 18, 1990: "Antibiotics and Antifungals."

Fifth Annual Smokey Mountain Infectious Disease Conference, Gatlinburg, Tennessee, May 26, 1990: "Antibiotics--Abuses and Misuses," "Pneumonia: An Update."

The University of Tennessee Medical Center at Knoxville Medical Grand Rounds, Knoxville, Tennessee, September 25, 1990: Empiric Use of Antibiotics."

Infections in the Neutropenic Patient Symposium, University of Southern California, Los Angeles, California, September 26, 1990: "Fungal Infections in the Neutropenic Patient."

Conveyor of "The Microbiologic Lessons of Antimicrobial Prophylaxis" Symposium, American Society for Microbiology, Dallas, Texas, May 6, 1991.

Primary CARE Conference, The Peabody Hotel, Memphis, Tennessee, August 16, 1991: "HIV - The Role of the Primary CARE Physician."

A Guaranteed Approach to Cost-Effective Management of Serious Institution-Acquired Infections, The Peabody Hotel, Memphis, Tennessee, September 24, 1991: "Pneumonia in the Elderly."

Michael S. Gelfand, M.D., F.A.C.P. 21

The Roerig Local Clinical Conference, Update on The Current Trends in The Management of Infectious Diseases, Fogelman Executive Center, Memphis, Tennessee, November 16, 1991: "Sepsis in the ICU."

The University of Alabama, Pinata of Pediatrics IV, Acapulco Princess Resort, Acapulco, Mexico, December 7-11, 1991: "Meningitis Update," "Antibiotic Resistance."

University of Tennessee, Department of Internal Medicine Lecture, Memphis, Tennessee, February 20, 1992: "Antibiotic Update."

Baylor University Medical Center, The McBee Memorial Lecture, Dallas, Texas, March 3, 1992: "Antibiotic Resistance in Clinical Practice."

Orlando Regional Medical Center and The University of Florida College of Medicine, Infectious Diseases and Antibiotic Therapy Conference, Hotel Royal Plaza, Walt Disney World Village, Lake Buena Vista, Florida, March 26-28, 1992: "3rd and 4th Generation Cephalosporins," "Oral Penicillins and Cephalosporins."

University of Tennessee School of Medicine, Neurology Grand Rounds, Memphis, Tennessee, March 11, 1992: "Neurologic Manifestations of HIV Infection."

Advances in Medicine--A Multi-Specialty Conference for Physicians, Methodist Hospitals of Memphis and The University of Tennessee College of Medicine, Hamilton, Bermuda, November 9-13, 1992: "Antibiotic Update," "Soft Tissue Infections."

Multi-Specialty Conference, Methodist Hospitals of Memphis, Scottsdale Princess, Scottsdale, Arizona, February 3-6, 1993: "Antibiotics in the Outpatient Setting," "HIV Update--The Role of the Primary Care Physician."

Infectious Disease Grand Rounds, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, February 23, 1993: "Clinical Vignettes."

Grand Rounds, Hunterdon Medical Center, Flemington, New Jersey, February 24, 1993: "Infections in the Elderly."

Arthritis - Infectious Disease Symposium, New Orleans, Louisiana, March 6, 1993: "Use of Quinolones in Primary Care."

University of South Alabama Medical Center, Mobile, Alabama, March 30, 1993: "Fungal Infections in the Compromised Host."

18th International Congress of Chemotherapy, Stockholm, Sweden, June 27-July 2, 1993. Urology Update, Holiday Inn Crowne Plaza, Memphis, Tennessee, July 17, 1993: "Urinary Tract Infection." Infectious Diseases Seminar, University of Louisville, Louisville, Kentucky, October 28, 1993, "CNS

Infections." Advances in Medicine--A Multi-Specialty Conference for Physicians, Hamilton Princess Hotel, Bermuda,

November 1-5, 1993: "Tuberculosis Update: Old Red Snappers Have New Sharp Teeth," "Oral Antibiotics Update."

All Russia Republican Children's Hospital, Moscow, Russia, December 2-3, 1993: "Fungal Infections," "Infections in a Compromised Host."

Multi-Specialty Conference in Westin La Paloma, Tucson, Arizona, February 17-19, 1994: "New Developments in Infectious Diseases," "Medicine in Russia."

Duke University Medical Center, Infectious Diseases Grand Rounds, May 16, 1994: "Tularemia." University of South Florida School of Medicine, May 17, 1994: VA Medical Center - "Anaerobic Infections." Infectious Diseases Grand Rounds "Tularemia" Medical Review for the Primary Care Physician, Longboat Key, Florida, July 28-30, 1994: "Diarrhea and

Food Poisoning," "Antibiotic Resistance" All Russia Republican Children's Hospital, Moscow, Russia, August 29-30, 1994: "New Infectious Diseases,"

"Antibiotic Resistance." Advances in Medicine, Maui, Hawaii, November 7-11, 1994: "Oral Antibiotics Update," "New Infectious

Diseases." Nursing in Neuro Seminar, Methodist Hospital School of Nursing, Memphis, Tennessee, May 11, 1995:

"Infections of the Nervous System." Medical Review for the Primary Care Physician, The Ritz-Carlton, Amelia Island, Florida, July 20-22, 1995:

"New Infectious Diseases," "Pneumonia." Advances in Medicine, Maui, Hawaii, Nov. 6-10, 1995 A multi-specialty conference for physicians co-

sponsored by Methodist Hospitals of Memphis and The University of Tennessee, Memphis College of Medicine. "Outpatient use of antibiotics", "New and emerging infections", "Fever of unknown origin - FUO"

Michael S. Gelfand, M.D., F.A.C.P. 22

"Update on Hemophilus influenzae infections" 2/2/96 Methodist Hospitals of Memphis Research Institute for Pediatric Hematology, Moscow, Russia 5/29-30/96 “Infections in Neutropenia”, “Viral

Respiratory Infections in Bone Marrow Transplant Patients” Medical Review for the Primary Care Physician, The Ritz-Carlton, Amelia Island, Florida, 7/18-20/96 "Oral

Antibiotics", "Sexually Transmitted Diseases" "Spirochetes: Lyme Disease, Leptospirosis and Relapsing Fever" University of Tennessee--Memphis ID

curriculum lecture. 10/1/96. "New and Emerging Diseases" and "Outpatient Use of Antibiotics” Multi-Specialty Conference for Primary

Care Physicians, The Orchid at Mauna Lani, Big Island of Hawaii. 2/3-4/97. "Neurologic Infections - Nursing Implications” Nursing in the Neurosciences Course, Methodist Hospitals of

Memphis School of Nursing. 4/5/97. "Early Presumptive Antifungal Therapy” Antimicrobial Therapy: Current Status and Future

Developments, The Peabody Hotel, Memphis, Tennessee. 5/24/97. "Invasive Candidiasis" - Medical Grand Rounds at the University of Florida (Jacksonville) Medical Center,

Jacksonville, FL. 7/16/97. "Diseases of Summer" and "Immunizations in the Adult” Medical Review for the Primary Care Physician,

The Ritz-Carlton, Amelia Island, FL. 7/19/97. "Adult Immunizations" Fourth Annual Primary Care Update, Columbia Centennial Medical Center,

Nashville, TN. 11/7/97. "Diseases of Summer" and "Oral Antibiotic Update” Multi-Specialty Conference for Primary Care

Physicians, The Orchid at Mauna Lani, Big Island of Hawaii. 1/29/98. "Antibiotic Update" and "Infectious Diarrhea” Medical Review for the Primary Care Physician, The Ritz-

Carlton, Amelia Island, FL. 7/23/98. "Surgical Wound Infections and Peri-operative Prophylaxis” Medical-surgical Conference, Memphis, TN.

9/17/98. The Association of Pakistani Physicians of North America Memphis, TN. 10/3/98 “Oral Antibiotics

Review”. Jackson-Madison County General Hospital 11/17/98 “A germ for The New Millenium”. Little Rock, Arkansas – The Capitol Hotel 2/6/99 “Winning Strategies for Managing Respiratory Disease” “Fungal Infection” and “Antibiotic Update” Multi-specialty Conference for Primary Care Physicians The

Orchid at Mauna Lani, Big Island of Hawaii. 2/11/99. University of Tennessee, Memphis – Medical Grand Rounds “Infections of Summer” – 7/14/99 “Antibiotic Update” and “Diseases of Summer” – Medical review for the Primary Care Physician, The Ritz-

Carlton, Amelia Island, FL. 7/22/99. “Antibiotic Update” –Infectious Disease Update for the Primary Care Physician. The Ritz Carlton, New

Orleans. 3/11/00. “Infections in the Diabetic Patient” – Critical Issues in Endocrinology and Metabolism for the New

Millennium. Kauai Marriott Resort & Beach Club, Kauai, Hawaii. 3/14/00. “Infections in Diabetes” – Infectious Diseases Intercity Grand Rounds, New Orleans, LA. 5/12/00. “Viral Infections” and “Staphylococcal Infections” – Medical Review for the Primary Care Physician, The

Ritz-Carlton, Amelia Island, FL. 7/20/00. “Infectious Disease Strategies in Primary Care: A Case-based Approach” – River Terrace Restaurant,

Memphis, TN. 10/12/00. “Mixed Aerobic-Anaerobic Infections” – Premier Place, Jackson, TN. 1/16/01. “Antibiotic Update” – Infectious Diseases Update for Primary Care Physicians March 9-10, 2001 New

Orleans, LA Hotel Inter-Continental. “Antibiotic Update”; “Infections in the Elderly” Update in Internal Medicine, July 16-20, 2001, Ritz-Carlton,

Naples, FL. “Mixed Aerobic-anaerobic Infections” 9/20/01 Medicine Grand Rounds, South Alabama School of Medicine,

Mobile, AL. “Pneumonia”; “Sepsis and Septic Shock” Nov 5-9, 2001 Advances in Medicine, The Ritz-Carlton Rose Hall,

Montego Bay, Jamaica. “Infections in The Elderly”; “CNS Infections” Feb 10-13, 2002 Infectious Diseases and Pulmonology

Update for the Primary Care Physician, The Ritz-Carlton, Kapalua, Maui, Hawaii.

Michael S. Gelfand, M.D., F.A.C.P. 23

“Infections in the Diabetic Patient” March 14-16, 2002 Cardiology and Endocrinology for the Primary Care Physician, The Cloister Sea Island, Georgia.

“Acute Encephalitis Update” 9/25/2002 Medicine Grand Rounds, University of Tennessee School of Medicine, Memphis, TN.

“Central Nervous System Infections”; “Skin and Soft Tissue Infections” Febr 21 and 22, 2003 New Orleans, LA - Infectious Diseases Update for Primary Care Physicians

“Antibiotic Resistance and New Antibiotics”; “Emerging Infections” 3/13-3/15/2003 Laguna Beach, CA – Multi Specialty Conference – A Medical Review for the Primary Care Physician

“Sexually Transmitted Diseases in Women” 8/22/03 Primary Care Issues in Women’s Health, The Peabody Hotel, Memphis, TN

“West Nile Virus Update” 9/17/03 Medicine Grand Rounds University of TN School of Medicine, Memphis, TN

“Antibiotic Resistance Update” 9/19/03 Arkansas Association of Health-System Pharmacists Fall Seminar Grand Casino Convention Center, Tunica, MS

“Sexually Transmitted Diseases in Men” 10/3/03 Issues in Men’s Health Madison Hotel, Memphis, TN “CNS Infections”, “Fungal Infections” Febr 21-22, 2004 New Orleans, LA – Infectious Diseases Update for

Primary Care Physicians “Infections in Bone Marrow Transplantation” June 29, 2004 Transplant Course for BMT nurses. Methodist

University Hospital, Memphis, TN “Fungal Infections”, “Update on Oral Antibiotics”, “Soft Tissue Infections” 7/21-7/22/2004 Medical Review

for The Primary Care Physician The Ritz-Carlton Amelia Island, FL “Update on Antibiotic Resistance” 7/23/2004 Tennessee Pharmacists Association, The Peabody Hotel,

Memphis, TN “Pneumonia” Medicine Grand Rounds UT-Chattanooga, 9/8/04 “ Clostridium difficile diarrhea” Medicine Grand Rounds UT-Knoxville, 9/21/04 “Community-Acquired Pneumonia”, “Soft Tissue Infections” Nov 8-11, 2004 Advances in Medicine. Maui,

Hawaii “Identification and treatment of fungal infections in non-immunocompromised ICU patients” 1/25/2005

Pulmonary and Critical Care Division Conference, University of TN Health Science Center, Memphis, TN “Update on Tratment Options for MRSA Infections” Surgical Conference Univ of Mississippi School of

Medicine, Jackson, MS “Update of Oral Antibiotic Therapy”, “Update of IV Antibiotic Therapy” March 4-5,2005 New Orleans, LA-

Infectious Diseases Update for Primary Care Physicians “Antibiotics”, “Antibiotic Resistance” – Lectures for MS-II medical students, May 1-3, 2005 “Tularemia Update” Basic Sciences Lecture 5/27/05 “Bioterrorism Update” – 5/31/05 “ Fungal Infections in HSCT patients” Symposium moderator ( Enzon symposium ) 6/10-6/11/05

Mandarin Oriental Hotel, Miami, FL “New Antibiotics” Internal Medicine Grand Rounds University of TN, Memphis 10/5/05 “New antibiotics”, “Infectious Diseases Vignettes” Nov 7-11,2005, Advances in Medicine, Maui, Hawaii “Avian Influenza” 1/10/2006 Hippocratic Society Journal Club Presentation, Hunt and Polo Club,

Memphis, TN “Life Threatening Infections” 2/10/2006 Fundamental Critical Care Support Course Methodist University

Hospital, Memphis, TN “Antibiotic Update”, “Infectious Diarrhea” March 30-31,2006, San Antonio, TX Infectious Disease Update for

the Primary Care Physicians “STDs in Men” Primary Care Issues in Men’s Health April 21-22, 2006 Atlanta, GA “Infections in The Elderly”, “Pneumococcal Infections” May 5, 2006, Sarasota, FL Geriatrics for the Primary

Care Physician “Skin Infections” 5/11/06 Dermatology Grand Rounds, University of TN, Memphis “ Infections and Treatment: Head to Toes”, “ STDs “ Medical Review for The Primary Care Physician July 17-

20, 2006, The Ritz-Carlton, Amelia Island, FL “Life Threatening Infections” 10/18/2006 Fundamental Critical Care Support Course Methodist University

Hospital, Memphis

Michael S. Gelfand, M.D., F.A.C.P. 24

HPV-related diseases and cervical cancer – prevention. Chattanooga ObGyn Society, Chattanooga, TN 10/28/06

“CNS Infections” The Advanced Neurosciences Day. Methodist University Hospital, Memphis, TN 11/20/2006

Infectious Diseases Update for the Primary Care Physicians March 16-17, 2007 “ STDs” “Tuberculosis Update” San Antonio, TX

STDs in Men” Primary Care Issues in Men’s Health April 21, 2007, Atlanta, GA “Endemic Mycoses” 4/26/07 Pulmonary Grand Rounds, University of TN Health Science Center,

Memphis “History of Antibiotics” Infectious Diseases Club. University of South Florida Medical School, Tampa, FL. 5/21/07 “Diabetic Foot Infection” – Internal Medicine Conference. University of South Florida Medical School,

Tampa, FL. 5/22/07 “History of Antibiotics” Infectious Diseases Grand Rounds, University of South Florida Medical School,

Tampa, FL 5/22/07 UT-Memphis Pulmonary Conference – “Nontuberculous mycobacterial pulmonary infections” 6/7/2007 Volunteer State Medical Association 103rd Annual Meeting. Grand Casino Hotel, Tunica, MS “HPV

infections” 6/9/07 Geriatrics for the Primary Care Physician July 2-5, 2007 The Fairmont Orchid, Kohala Coast, Hawaii. “

Pneumococcal Infections”; “Infections in Nursing Home Patients” Medical review for the Primary care Physician. July 16-19, 2007. Amelia Island, FL. “Antibiotic Update”,

“Tuberculosis – Past, Present and Future”. Infectious Endocarditis Update for Cardiology Fellows, UT-HSC, Memphis, TN 8/16/07 “STDs in Women” Primary Care Issues in Women’s Health, The Holiday Inn – Univ of Memphis, Memphis,

TN 8/18/2007 “Nontuberculous mycobacteria –cutaneous manifestations” – Dermatology Grand rounds UTHSC, Memphis,

TN 8/30/07 “Gram Positive Infections” Infectious Diseases Conference, Tampa General Hospital, Tampa, FL 9/25/07 “Antibiotic Resistance – 2007” University Community Hospital, Tampa, FL 9/25/07 2007 TN chapter American College of Physicians, Chattanooga, TN. The Chattanoogan Hotel. Faculty for

SEP-based Learning Session for Recertification 10/13/07 “ Cutaneous manifestations of endemic mycoses “ Dermatology Grand Rounds UTHSC, Memphis, TN

10/18/07 “Fungal vignettes” Internal Medicine Grand Rounds, Dallas Methodist Hospital, Dallas, TX 10/22/07 “Antibiotic Update”, “Advances in Adult Vaccinations” Advances in Medicine Course Nov 5-8, 2007 Grand

Cayman Islands “ Histoplasmosis 2007 “ UTHSC Pulmonary Grand Rounds 11/26/07 “Update in the Treatment and Prevention of Infections in Cancer Patients” A teleconference to All-Russia

Pediatric Oncology Hospital, Moscow, Russia from St. Jude’s Children’s Hospital. Euro-Asian Learners Group. “Pneumonia in The Elderly”, “Infections in The Elderly” – Geriatrics for The Primary Care Physician, Febr

2/14/2008, The Ritz-Carlton, Phoenix, Arizona “MRSA-2008” UTHSC Pulmonary Grand Rounds 2/20/2008 “Cutaneous manifestations of opportunistic mycoses” Dermatology Grand Rounds UTHSC, Memphis, TN

3/6/08 Internal Medicine Maintenance of Certification Course. 3/15/08. Holiday Inn. U of Memphis. Faculty. Recent

Advances in Internal Medicine with audience response “ Infections in Bone Marrow Transplantation” UTHSC Pulmonary Grand Rounds 3/25/08 “ Infections in Solid-Organ Transplantation” UTHSC Pulmonary Grand Rounds 4/17/08 Infectious Diseases Update for the Primary Care Physicians Moderator and presenter. May 2-3, 2008 Ritz-

Carlton Hotel, Denver, Colorado “ Skin and Soft Tissue Infections” “ Update on Endocarditis” “ CNS infections in Hematology-Oncology patients” A teleconference to All-Russia Pediatric Oncology

Hospital, Moscow, Russia from St. Jude’s Hospital. Euro-Asian Learners Group 6/18/08 “Treatment of Healthcare Associated Infections” Jackson-Madison County General Hospital Grand Rounds

7/15/08

Michael S. Gelfand, M.D., F.A.C.P. 25

Medical review for the Primary care Physician. July 21-24, 2008. Ritz-Carlton, Amelia Island, FL. Course director. Presentations: “MRSA Update”, “Immunization in Adults”.

“Antibiotics in Hematology-Oncology” September 17th, 2008 A teleconference to All-Russia Pediatric Oncology Hospital, Moscow, Russia from St. Jude’s Hospital. Euro-Asian Learners Group

University of TN Internal Medicine Grand Rounds November 12th, 2008 “Health Care Associated Infections – 2008”

University of TN Division of Pulmonary Medicine Conference November 18 th, 2008 “MOTT University of TN Division of Cardiology Conference December 1st, 2008 “Endocarditis Update” University of Mississippi School of Medicine, Jackson, MS March 6 th, 2009. ID Grand Rounds “MRSA

Update” Eastern Carolina School of Medicine, Infectious Diseases Grand Rounds. “MRSA Update” March 25, 2009 “Central Nervous System Infections”; “ Antibiotics Update” March 27-28, 2009 New Orleans, LA - Infectious

Diseases Update for Primary Care Physician Medical review for the Primary care Physician. July 13-15, 2009. Ritz-Carlton, Amelia Island, FL.

Presentations: “Life Threatening Infections”, “Infections in Primary Care Setting” Advances in Medicine Course, 11/5-11/7/2009. West Palm Beach, FL. Ritz-Carlton. “MRSA Update”, “

Immunization in Adults” South Alabama School of Medicine Infectious Diseases Grand Rounds “ MRSA Update” 11/19/2009 Baylor University Medical Center, Dallas, TX – Internal Medicine Grand Rounds “MRSA Update” –

1/19/2010 Infectious Diseases Update for the Primary Care Physicians. Charleston, SC. Charleston Place Hotel. Febr 26-

27, 2010. “CNS Infections”, “Immunization in Adults”. Course Director. Medical review for the Primary care Physician. July 20-21, 2010. Ritz-Carlton, Amelia Island, FL.

Presentations: “STDs”, “Antibiotic Update” UTHSC-Memphis Dermatology Grand Rounds “Cutaneous manifestations of atypical mycobacterial

infections” Sept 23. 2010 UTHSC-Memphis Neurosurgery Grand Rounds “Antibiotics in Neurosurgery” Dec 3, 2010 UTHSC Division of Pulmonary Medicine Conference Dec 16, 2010 “ MOTT” UTHSC Internal Medicine Grand Rounds Febr 23, 2011 “ Syphilis 2011” Infectious Diseases Update for the Primary Care Physicians. Charleston, SC. Charleston Place Hotel. Febr 25-

26, 2011. “Skin and Soft Tissue Infections”, “Immunization in Adults”. Course Director. VII International Symposium “Biological Basis of Therapy of Oncological and Hematological Diseases” –

Moscow, Russia June 3, 2011 “Rational Approach to Antibacterial Therapy in Hematology/Oncology” 13th Annual Adult and Pediatric Infectious Diseases Update for the Primary Care Physician Feb 17 & 18, 2012.

Memphis, TN. “Sexually Transmitted Diseases “, “Interesting Cases Panel”. Course Director. UTHSC-Memphis Internal Medicine Grand Rounds “Fungal Infections in the 21st century” April 30th 2014 “Primary Care Issues in Women’s Health” Aug 8, 2014. Memphis, TN. “Sexually Transmitted Infections in

Women” “HIV Enteropathy” Infectious Diseases Grand Rounds USF-Tampa, FL Feb 11, 2015 “Fungal Infections in the 21st Century” Internal Medicine Grand Rounds USF-Tampa, FL Feb 12, 2015 “Infections in The ER” Emergency Medicine Residents – UTHSC-Memphis July 22, 2015 “STDs in ER” Emergency Medicine Grand Rounds – UTHSC-Memphis October 29, 2015 “McBee Memorial Lecture Baylor University Medical Center, Dallas, TX – “Fungal Infections Update” –

11/17/15 STD Update – Internal Medicine Conference. Baylor University Medical Center, Dallas, TX – 11/17/15 “Infections in The Elderly” UTHSC-Memphis Internal Medicine Grand Rounds 5/4/2016 “Antifungal Therapy” USF ID Grandrounds, Tampa, FL 10/24/16